<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Methods of term labour induction for women with a previous caesarean section - West, HM - 2017 | Cochrane Library</title> <meta content="Methods of term labour induction for women with a previous caesarean section - West, HM - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009792.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Methods of term labour induction for women with a previous caesarean section - West, HM - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009792.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009792.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Methods of term labour induction for women with a previous caesarean section" name="citation_title"/> <meta content="Helen M West" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Marta Jozwiak" name="citation_author"/> <meta content="Leiden University Medical Center" name="citation_author_institution"/> <meta content="jozwiak.marta@gmail.com" name="citation_author_email"/> <meta content="Jodie M Dodd" name="citation_author"/> <meta content="The University of Adelaide, Women's and Children's Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD009792.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/06/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009792.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009792.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009792.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Vaginal Birth after Cesarean; Dinoprostone [administration &amp; dosage]; Early Termination of Clinical Trials; Labor, Induced [*methods]; Misoprostol [administration &amp; dosage]; Oxytocics [*administration &amp; dosage]; Oxytocin [administration &amp; dosage]; Randomized Controlled Trials as Topic; Uterine Rupture [etiology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009792.pub3&amp;doi=10.1002/14651858.CD009792.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZCrlluee";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009792\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009792\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009792.pub3",title:"Methods of term labour induction for women with a previous caesarean section",firstPublishedDate:"Jun 9, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009792.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009792.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009792.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009792.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009792.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009792.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009792.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009792.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009792.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009792.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7268 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009792.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-sec-0126"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-sec-0076"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-sec-0120"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/table_n/CD009792StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/table_n/CD009792StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Methods of term labour induction for women with a previous caesarean section</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information#CD009792-cr-0002">Helen M West</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information#CD009792-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Marta Jozwiak</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information#CD009792-cr-0004">Jodie M Dodd</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information/en#CD009792-sec-0133">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 June 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009792.pub3">https://doi.org/10.1002/14651858.CD009792.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009792-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009792-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009792-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009792-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009792-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009792-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009792-abs-0001" lang="en"> <section id="CD009792-sec-0001"> <h3 class="title" id="CD009792-sec-0001">Background</h3> <p>Women with a prior caesarean delivery have an increased risk of uterine rupture and for women subsequently requiring induction of labour it is unclear which method is preferable to avoid adverse outcomes. This is an update of a review that was published in 2013. </p> </section> <section id="CD009792-sec-0002"> <h3 class="title" id="CD009792-sec-0002">Objectives</h3> <p>To assess the benefits and harms associated with different methods used to induce labour in women who have had a previous caesarean birth. </p> </section> <section id="CD009792-sec-0003"> <h3 class="title" id="CD009792-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth's Trials Register (31 August 2016) and reference lists of retrieved studies. </p> </section> <section id="CD009792-sec-0004"> <h3 class="title" id="CD009792-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing any method of third trimester cervical ripening or labour induction, with placebo/no treatment or other methods in women with prior caesarean section requiring labour induction in a subsequent pregnancy. </p> </section> <section id="CD009792-sec-0005"> <h3 class="title" id="CD009792-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed studies for inclusion and trial quality, extracted data, and checked them for accuracy. </p> </section> <section id="CD009792-sec-0006"> <h3 class="title" id="CD009792-sec-0006">Main results</h3> <p>Eight studies (data from 707 women and babies) are included in this updated review. Meta‐analysis was not possible because studies compared different methods of labour induction. All included studies had at least one design limitation (i.e. lack of blinding, sample attrition, other bias, or reporting bias). One study stopped prematurely due to safety concerns. </p> <p><b>Vaginal PGE2 versus intravenous oxytocin</b> (one trial, 42 women): no clear differences for caesarean section (risk ratio (RR) 0.67, 95% confidence interval (CI) 0.22 to 2.03, evidence graded low), serious neonatal morbidity or perinatal death (RR 3.00, 95% CI 0.13 to 69.70, evidence graded low), serious maternal morbidity or death (RR 3.00, 95% CI 0.13 to 69.70, evidence graded low). Also no clear differences between groups for the reported secondary outcomes. The GRADE outcomes vaginal delivery not achieved within 24 hours, and uterine hyperstimulation with fetal heart rate changes were not reported. </p> <p><b>Vaginal misoprostol versus intravenous oxytocin</b> (one trial, 38 women): this trial stopped early because one woman who received misoprostol had a uterine rupture (RR 3.67, 95% CI 0.16 to 84.66) and one had uterine dehiscence. No other outcomes (including GRADE outcomes) were reported. </p> <p><b>Foley catheter versus intravenous oxytocin</b> (one trial, subgroup of 53 women): no clear difference between groups for vaginal delivery not achieved within 24 hours (RR 1.47, 95% CI 0.89 to 2.44, evidence graded low), uterine hyperstimulation with fetal heart rate changes (RR 3.11, 95% CI 0.13 to 73.09, evidence graded low), and caesarean section (RR 0.93, 95% CI 0.45 to 1.92, evidence graded low). There were also no clear differences between groups for the reported secondary outcomes. The following GRADE outcomes were not reported: serious neonatal morbidity or perinatal death, and serious maternal morbidity or death. </p> <p><b>Double‐balloon catheter versus vaginal PGE2</b> (one trial, subgroup of 26 women): no clear difference in caesarean section (RR 0.97, 95% CI 0.41 to 2.32, evidence graded very low). Vaginal delivery not achieved within 24 hours, uterine hyperstimulation with fetal heart rate changes, serious neonatal morbidity or perinatal death, and serious maternal morbidity or death were not reported. </p> <p><b>Oral mifepristone versus Foley catheter</b> (one trial, 107 women): no primary/GRADE outcomes were reported. Fewer women induced with mifepristone required oxytocin augmentation (RR 0.54, 95% CI 0.38 to 0.76). There were slightly fewer cases of uterine rupture among women who received mifepristone, however this was not a clear difference between groups (RR 0.29, 95% CI 0.08 to 1.02). No other secondary outcomes were reported. </p> <p><b>Vaginal isosorbide mononitrate (IMN) versus Foley catheter</b> (one trial, 80 women): fewer women induced with IMN achieved a vaginal delivery within 24 hours (RR 2.62, 95% CI 1.32 to 5.21, evidence graded low). There was no difference between groups in the number of women who had a caesarean section (RR 1.00, 95% CI 0.39 to 2.59, evidence graded very low). More women induced with IMN required oxytocin augmentation (RR 1.65, 95% CI 1.17 to 2.32). There were no clear differences in the other reported secondary outcomes. The following GRADE outcomes were not reported: uterine hyperstimulation with fetal heart rate changes, serious neonatal morbidity or perinatal death, and serious maternal morbidity or death. </p> <p><b>80 mL versus 30 mL Foley catheter</b> (one trial, 154 women): no clear difference between groups for the primary outcomes: vaginal delivery not achieved within 24 hours (RR 1.05, 95% CI 0.91 to 1.20, evidence graded moderate) and caesarean section (RR 1.05, 95% CI 0.89 to 1.24, evidence graded moderate). However, more women induced using a 30 mL Foley catheter required oxytocin augmentation (RR 0.81, 95% CI 0.66 to 0.98). There were no clear differences between groups for other secondary outcomes reported. Several GRADE outcomes were not reported: uterine hyperstimulation with fetal heart rate changes, serious neonatal morbidity or perinatal death, and serious maternal morbidity or death. </p> <p><b>Vaginal PGE2 pessary versus vaginal PGE2 tablet</b> (one trial, 200 women): no difference between groups for caesarean section (RR 1.09, 95% CI 0.74 to 1.60, evidence graded very low), or any of the reported secondary outcomes. Several GRADE outcomes were not reported: vaginal delivery not achieved within 24 hours, uterine hyperstimulation with fetal heart rate changes, serious neonatal morbidity or perinatal death, and serious maternal morbidity or death. </p> </section> <section id="CD009792-sec-0007"> <h3 class="title" id="CD009792-sec-0007">Authors' conclusions</h3> <p>RCT evidence on methods of induction of labour for women with a prior caesarean section is inadequate, and studies are underpowered to detect clinically relevant differences for many outcomes. Several studies reported few of our prespecified outcomes and reporting of infant outcomes was especially scarce. The GRADE level for quality of evidence was moderate to very low, due to imprecision and study design limitations. </p> <p>High‐quality, adequately‐powered RCTs would be the best approach to determine the optimal method for induction of labour in women with a prior caesarean birth. However, such trials are unlikely to be undertaken due to the very large numbers needed to investigate the risk of infrequent but serious adverse outcomes (e.g. uterine rupture). Observational studies (cohort studies), including different methods of cervical ripening, may be the best alternative. Studies could compare methods believed to provide effective induction of labour with low risk of serious harm, and report the outcomes listed in this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009792-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009792-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009792-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009792-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009792-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009792-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009792-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009792-abs-0004" lang="en"> <h3>Induction methods for women who have had a prior caesarean birth</h3> <p><b>What is the issue?</b> </p> <p>Labour induction is a common procedure, carried out when it is judged to be safer for a baby to be born than to continue a pregnancy. When a woman who has had a caesarean in the past gives birth, current clinical practice supports helping her to have a vaginal birth. However, there is a higher risk of complications from induction for women who have previously had a caesarean section. </p> <p>Methods for induction include: prostaglandin medication (including oral or vaginal prostaglandins E2 (PGE2) or misoprostol); mifepristone; mechanical methods (including Foley catheters and double‐balloon catheters); nitric oxide donors (such as isosorbide mononitrate); and oxytocin. This review looked at the harms and benefits of different methods for induction of labour in women with a prior caesarean birth, if induction of labour was required in their current pregnancy. </p> <p><b>Why is this important?</b> </p> <p>Lots of women have caesareans: across the world between one in four and one in two babies are born by caesarean section. Many women go on to have another pregnancy, and we want to know how to deliver these babies safely. Women with a prior caesarean birth have an increased risk of uterine scar rupture, particularly when labour is induced. This is a serious complication, often leading to negative outcomes for mother and child, such as hysterectomy, genitourinary tract injury, and postpartum blood transfusions for the mother, and neurological impairment or even death for the child. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for studies on 31 August 2016. Eight small randomised controlled trials are included in this updated review, with data from 707 women and babies. The studies compared different methods of inducing labour, so results could not be combined. </p> <p>There were design problems in all of the trials: women and health professionals knew which induction method was being used in seven out of eight trials, which may have affected clinical decisions. Women were left out of the analysis in some trials, and trials often did not report important outcomes (vaginal birth not achieved within 24 hours of induction, overstimulation of the uterus with changes to the baby's heart rate, caesarean section, serious illness or death of the baby, serious illness or death of the mother). </p> <p>The trials were too small to show clear differences. The quality of the evidence was very low, low, or moderate, because the trials were small and had high risk of bias. We cannot be certain about the results, and future research may show something different. </p> <p><b>What does this mean?</b> </p> <p>There is not enough information available from randomised controlled trials to advise on the best methods of labour induction in women with a previous caesarean birth. More high‐quality randomised controlled trials are needed to find out which method is best for mothers and babies. However, such trials are unlikely to be carried out because they would need a very large number of participants in order to study the risk of infrequent but serious outcomes (such as rupture of the woman's uterus). Other types of studies (i.e. non‐randomised controlled trials) might be the best alternative. Future research could focus on those methods of induction that are believed to be effective and have a low risk of serious harm. The outcomes identified as important in this review could be utilised in future studies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009792-sec-0126" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009792-sec-0126"></div> <h3 class="title" id="CD009792-sec-0127">Implications for practice</h3> <section id="CD009792-sec-0127"> <p>There is insufficient information available from randomised controlled trials to inform clinical decisions regarding the optimal method of induction of labour in women with a prior caesarean birth. For women with an unfavourable cervix who require induction of labour, the risks and benefits of mechanical and pharmacologic options of cervical ripening, as well as labour induction and augmentation need to be considered. Whilst the data in this review are insufficient to inform practice in terms of the best method of induction for women with a prior caesarean, it is important to highlight that one study, which used misoprostol, was stopped early due to serious complications associated with its use. </p> </section> <h3 class="title" id="CD009792-sec-0128">Implications for research</h3> <section id="CD009792-sec-0128"> <p>Appropriately designed and conducted randomised trials are required to evaluate methods of induction of labour for women who have had a prior caesarean birth, including evaluation of mechanical methods of induction, with adequate reporting of clinically relevant maternal and infant outcomes. As these are not likely to be undertaken due to results from previous reports, and if undertaken are likely to be underpowered to evaluate the risk of infrequent but serious adverse outcomes, we suggest adequately powered prospective cohort studies. These studies could compare methods believed to provide effective induction of labour with low risk of serious harm, and report the outcomes identified as important in this review. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009792-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009792-sec-0029"></div> <div class="table" id="CD009792-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal PGE2 versus intravenous (IV) oxytocin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal PGE2 compared with IV oxytocin for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with one previous lower segment caesarean section and requiring labour induction due to prolonged pregnancy or pre‐eclampsia, singleton in cephalic presentation, GA ≥ 37 weeks, BS &lt; 9, no cephalopelvic disproportion anticipated<br/> <b>Setting:</b> UK<br/> <b>Intervention:</b> vaginal prostaglandin E2 (2.5 mg pessary)<br/> <b>Comparison:</b> intravenous oxytocin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oxytocin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with prostaglandin E2</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/> (0.22 to 2.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>191 per 1000<br/> (63 to 580) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity/perinatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/> (0.13 to 69.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/> (0.13 to 69.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>GA</b> : gestational age; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Wide CI crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009792-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vaginal misoprostol versus intravenous (IV) oxytocin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared with IV oxytocin for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with a previous caesarean section<br/> <b>Setting:</b> USA<br/> <b>Intervention:</b> vaginal misoprostol 25 μg every 6 hours (maximum of 4 doses)<br/> <b>Comparison:</b> intravenous oxytocin "per a standardised infusion protocol" see <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> (dose/regime not reported) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with misoprostol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oxytocin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009792-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Foley catheter versus intravenous (IV) oxytocin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Foley catheter compared with IV oxytocin for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women with a previous low transverse caesarean section, singleton live pregnancy with cephalic presentation, period of gestation &gt; 28 weeks and BS &lt; 5 were included in the study, with unfavourable cervix<br/> <b>Setting:</b> Chandigarh, India. July 2004–November 2005<br/> <b>Intervention:</b> Foley catheter balloon inflated with 30 mL of sterile saline<br/> <b>Comparison:</b> intravenous oxytocin (low dose IV oxytocin, starting at 1 mU/min and increasing if contractions were not frequent after 1 hour) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oxytocin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Foley catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.47<br/> (0.89 to 2.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>653 per 1000<br/> (396 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.11<br/> (0.13 to 73.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.45 to 1.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>370 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>344 per 1000<br/> (167 to 711) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Wide confidence interval crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009792-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Double‐balloon catheter versus vaginal PGE2</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Double‐balloon catheter compared with vaginal PGE2 for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with a previous caesarean section (subgroup of all women in the study) with intact fetal membranes, cephalic position and unfavourable cervix, with indications for induction of labour<br/> <b>Setting:</b> 7 labour wards in Denmark, December 2002‐September 2005 </p> <p><b>Intervention:</b> double‐balloon catheter inserted through the cervical canal with 80 mL of saline installed stepwise in the uterine balloon and 80 mL saline in the cervicovaginal balloon<br/> <b>Comparison:</b> vaginal prostaglandin E2 (dinoprostone 3 mg vaginal tablet) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with prostaglandin E2</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with double‐balloon catheter</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.41 to 2.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>571 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>554 per 1000<br/> (234 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One study with design limitations (risk of bias, downgraded 1 level).<br/> <sup>2</sup>Wide confidence interval crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009792-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Oral mifepristone versus Foley catheter</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Oral mifepristone compared with Foley catheter for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section<br/> <b>Setting:</b> India, 2012‐2014<br/> <b>Intervention:</b> oral mifepristone (400 mg) orally at 40 + 5. All women were reassessed 24 hours and 48 hours later. If BS &gt; 6, amniotomy was performed, followed by oxytocin infusion. If after 48 hours, BS was &lt; 6, induction of labour was done with oxytocin infusion<br/> <b>Comparison:</b> Foley catheter with 30 mL normal saline inserted at 40 + 5 </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with mifepristone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Foley catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009792-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Vaginal isosorbide mononitrate versus Foley catheter</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal isosorbide mononitrate versus Foley catheter for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women with 1 previous lower segment caesarean section at 37 weeks and beyond, with a BS of ≤ 6, intact membranes, reactive non‐stress test, normal umbilical arterial Doppler indices, absence of labour and willingness of women to participate in the study<br/> <b>Setting:</b> Egypt<br/> <b>Intervention:</b> vaginal isosorbide mononitrate (40 mg) inserted into the posterior fornix of the vagina once<br/> <b>Comparison:</b> Foley catheter No. 14‐16 Fr inserted into the endocervical canal, beyond the internal os and inflated with 50‐60 mL of normal saline </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Foley catheter</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with isosorbide mononitrate</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.63<br/> (1.32 to 5.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>526 per 1000<br/> (264 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.39 to 2.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000<br/> (68 to 453) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>Fr</b> : French; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> One study with design limitations (risk of bias, downgraded 1 level).<br/> <sup>2</sup> Small sample size (imprecision, downgraded 1 level).<br/> <sup>3</sup> Wide CI crossing the line of no effect, small sample size (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009792-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">80 mL versus 30 mL Foley catheter</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>80 mL Foley catheter versus 30 mL Foley catheter for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women who previously had a lower segment CS and now have a singleton cephalic presentation after at least 36 completed weeks, not in labour, with intact membranes and BS of &lt; 6<br/> <b>Setting:</b> a large tertiary centre in South India, which carries out ˜15,000 deliveries every year. October 2011‐December 2013<br/> <b>Intervention:</b> a 16 Fr Foley catheter was introduced into the cervix beyond the internal os and the bulb inflated with 80 mL of sterile water<br/> <b>Comparison:</b> a 16 Fr Foley catheter was introduced into the cervix beyond the internal os and the bulb inflated with 30 mL of sterile water </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with 30 mL Foley catheter</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with 80 mL Foley catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.91 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>818 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>859 per 1000<br/> (745 to 982) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.89 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>766 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>805 per 1000<br/> (682 to 950) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>Fr</b> : French; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Small sample size (imprecision, downgraded 1 level). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009792-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Vaginal PGE2 pessary versus vaginal PGE2 tablet</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal PGE2 pessary versus vaginal PGE2 tablet for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with a previous caesarean section, a live singleton fetus (37‐42 weeks of gestation) in cephalic presentation and a reactive non‐stress test, BS of ≤ 7 before onset of labour, no spontaneous contractions (&lt; 4 contractions within 20 minutes)<br/> <b>Setting:</b> large Governmental hospital, Saudi Arabia. February 2009‐March 2013<br/> <b>Intervention:</b> vaginal PGE2 pessary (10 mg dinoprostone sustained‐release vaginal pessary)<br/> <b>Comparison:</b> vaginal PGE2 tablet (1.5 mg dinoprostone vaginal tablet) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dinoprostone tablet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dinoprostone pessary</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.09<br/> (0.74 to 1.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1000<br/> (244 to 528) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One study with design limitations (risk of bias, downgraded 1 level).<br/> <sup>2</sup>Wide confidence crossing the line of no effect, small sample size (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009792-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009792-sec-0030"></div> <p>This review is an update of a review first published in 2013 (<a href="./references#CD009792-bbs2-0058" title="JozwiakM , DoddJM . Methods of term labour induction for women with a previous caesarean section. Cochrane Database of Systematic Reviews2013, Issue 3. [DOI: 10.1002/14651858.CD009792.pub2] ">Jozwiak 2013</a>). </p> <section id="CD009792-sec-0031"> <h3 class="title" id="CD009792-sec-0031">Description of the condition</h3> <p>Worldwide, caesarean birth is common. In Australia in 2007, almost 31% of women gave birth by caesarean section (<a href="./references#CD009792-bbs2-0041" title="LawsP , SullivanEA . Australia's Mothers and Babies 2007. Cat. no. PER 48. Canberra: AIHW, 2009. ">Laws 2009</a>), with similar figures reported from the USA (<a href="./references#CD009792-bbs2-0044" title="MartinJA , SuttonPD , VenturaSJ , MenackerF , KirmeyerS , MathewsTJ . National Vital Statistics Reports. Births: Final Data for 2006. www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_07.pdf(accessed July 2011). ">Martin 2009</a>). While the overall rate of caesarean section is lower in the UK, accounting for approximately 25% of all births (<a href="./references#CD009792-bbs2-0046" title="NHS. NHS Maternity Statistics 2008‐09. The Health and Social Care Information Centre, 2009. ">NHS 2009</a>), rates of almost 50% have been reported in some private hospitals in Argentina, Brazil and Chile (<a href="./references#CD009792-bbs2-0021" title="BelizanJM , AlthabeF , BarrosFC , AlexanderS . Rates and implications of caesarean sections in Latin America: ecological study. BMJ1999;319(7222):1397‐400. ">Belizan 1999</a>). Women who have had a prior caesarean birth are at increased risk of complications during a subsequent labour, including risk of uterine rupture, presenting unique circumstances related to the mode of birth in a subsequent pregnancy. The particular benefits and harms associated with both elective repeat caesarean section and vaginal birth after caesarean section are discussed in the Cochrane Review 'Planned elective repeat caesarean section versus planned vaginal birth for women with a previous caesarean section' (<a href="./references#CD009792-bbs2-0030" title="DoddJM , CrowtherCA , HuertasE , GuiseJM , HoreyD . Planned elective caesarean section versus planned vaginal birth for women with a previous caesarean birth. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD004224.pub2] ">Dodd 2004</a>). Current clinical practice guidelines support vaginal birth and trial of labour among women who have had a prior caesarean birth (<a href="./references#CD009792-bbs2-0019" title="ACOG . Committee Opinion No 342: induction of labor for vaginal birth after cesarean delivery. Obstetrics &amp; Gynecology2006;108(2):465‐8. ">ACOG 2006</a>; <a href="./references#CD009792-bbs2-0052" title="National Collaborating Centre for Women’s and Children’s Health. Induction of Labour. Clinical Guideline no 70. London: RCOG press, 2008. ">RCOG 2008</a>). </p> <p>Induction of labour is a common obstetric intervention, with between 20% and 30% of births reported to occur following induction of labour (<a href="./references#CD009792-bbs2-0041" title="LawsP , SullivanEA . Australia's Mothers and Babies 2007. Cat. no. PER 48. Canberra: AIHW, 2009. ">Laws 2009</a>; <a href="./references#CD009792-bbs2-0044" title="MartinJA , SuttonPD , VenturaSJ , MenackerF , KirmeyerS , MathewsTJ . National Vital Statistics Reports. Births: Final Data for 2006. www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_07.pdf(accessed July 2011). ">Martin 2009</a>; <a href="./references#CD009792-bbs2-0048" title="Euro‐PERISTAT Project. The European Perinatal Health Report. www.europeristat.com2008. ">Peristat 2008</a>). The percentage of women requiring induction of labour after a previous caesarean birth is thought to be similar to that of other pregnant women (<a href="./references#CD009792-bbs2-0042" title="LocatelliA , RegaliaAL , GhidiniA , CirielloE , BiffiA , PezzulloJC . Risks of induction of labour in women with a uterine scar from previous low transverse caesarean section. BJOG: an international journal of obstetrics and gynaecology2004;111(12):1394‐9. ">Locatelli 2004</a>). For women who have had a previous caesarean birth and who require induction of labour in a subsequent pregnancy, it is unclear whether labour should be induced, or if birth should occur by repeat elective caesarean section. This question is considered in more detail in the Cochrane Review 'Elective repeat caesarean section versus induction of labour for women with a previous caesarean birth' (<a href="./references#CD009792-bbs2-0031" title="DoddJM , CrowtherCA . Elective repeat caesarean section versus induction of labour for women with a previous caesarean birth. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD004906.pub3] ">Dodd 2006</a>). </p> <p>An uncommon, but potentially life‐threatening complication for both the woman and her infant associated with vaginal birth, is that of uterine scar rupture (where the previous caesarean scar breaks down). Uterine scar rupture is associated with a significant risk of maternal morbidity, such as hysterectomy, genitourinary tract injury, postpartum blood transfusions, and maternal death (<a href="./references#CD009792-bbs2-0026" title="ChuahanSP , MartinJN , HenrichsCE , MorrisonJC , MagannEF . Maternal and perinatal complications with uterine rupture in 147,075 patients who attempted vaginal birth after cesarean delivery: a review of the literature. American Journal of Obstetrics and Gynecology2003;189:408‐17. ">Chuahan 2003</a>; <a href="./references#CD009792-bbs2-0057" title="ZwartJJ , RichtersJM , OryF , DeVriesJI , BloemenkampKW , VanRoosmalenJ . Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population‐based study of 371 000 pregnancies. BJOG: an international journal of obstetrics and gynaecology2008;115:842‐50. ">Zwart 2008</a>). Increased infant morbidity and perinatal death have been reported (<a href="./references#CD009792-bbs2-0026" title="ChuahanSP , MartinJN , HenrichsCE , MorrisonJC , MagannEF . Maternal and perinatal complications with uterine rupture in 147,075 patients who attempted vaginal birth after cesarean delivery: a review of the literature. American Journal of Obstetrics and Gynecology2003;189:408‐17. ">Chuahan 2003</a>). Although there is variation in findings in different studies, in women who have had previous caesarean birth, uterine rupture is reported to occur in about 8 in 1000 births with spontaneous labour, however, this risk is thought to be almost doubled when labour is induced (<a href="./references#CD009792-bbs2-0047" title="National Institutes of Health Consensus Development Conference Panel. [National Institutes of Health Consensus Development conference statement: vaginal birth after cesarean: new insights March 8‐10, 2010]. Obstetrics and Gynecology. 2010. ">NIH consensus 2010</a>). </p> <p>The focus of this current systematic review is to address the method of induction of labour, should it be required, in women who have had a previous caesarean section. The review draws on the methodology of the Cochrane generic protocol related to methods of induction of labour (<a href="./references#CD009792-bbs2-0036" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074.pub2] ">Hofmeyr 2009</a>). </p> </section> <section id="CD009792-sec-0032"> <h3 class="title" id="CD009792-sec-0032">Description of the intervention</h3> <p>Induction of labour is carried out when the risks of continuing the pregnancy outweigh the benefits. Common indications for labour induction include post‐term pregnancy, prelabour rupture of membranes, intrauterine growth restriction of the fetus, maternal hypertensive disorders, and other maternal conditions. Many different methods are available for labour induction, including pharmacological methods (mainly prostaglandin analogues and oxytocin), and mechanical methods, such as Foley catheters. </p> </section> <section id="CD009792-sec-0033"> <h3 class="title" id="CD009792-sec-0033">How the intervention might work</h3> <p>Prospective and retrospective cohort studies have shown an increased risk of uterine rupture in women who have had a prior caesarean birth following induction of labour, especially when prostaglandin preparations are used for cervical ripening (<a href="./references#CD009792-bbs2-0039" title="LandonMB , HauthJC , LevenoKJ , SpongCY , LeindeckerS , VarnerMW , et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. New England Journal of Medicine2004;351(25):2581‐9. ">Landon 2004</a>; <a href="./references#CD009792-bbs2-0043" title="Lydon‐RochelleM , HoltVL , EasterlingTR , MartinDP . Risk of uterine rupture during labor among women with a prior cesarean delivery. New England Journal of Medicine2001;345(1):3‐8. ">Lydon‐Rochelle 2001</a>; <a href="./references#CD009792-bbs2-0054" title="SmithGC , PellJP , PasupathyD , DobbieR . Factors predisposing to perinatal death related to uterine rupture during attempted vaginal birth after caesarean section: retrospective cohort study. BMJ2004;329(7462):375. ">Smith 2004</a>). The risk of uterine rupture following mechanical dilation for ripening of the cervix is reported to be lower than with prostaglandins (<a href="./references#CD009792-bbs2-0024" title="BujoldE , BlackwellSC , GauthierRJ . Cervical ripening with transcervical Foley catheter and the risk of uterine rupture. Obstetrics &amp; Gynecology2004;103(1):18‐23. ">Bujold 2004</a>; <a href="./references#CD009792-bbs2-0039" title="LandonMB , HauthJC , LevenoKJ , SpongCY , LeindeckerS , VarnerMW , et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. New England Journal of Medicine2004;351(25):2581‐9. ">Landon 2004</a>; <a href="./references#CD009792-bbs2-0051" title="RavasiaDJ , WoodSL , PollardJK . Uterine rupture during induced trial of labor among women with previous cesarean delivery. American Journal of Obstetrics and Gynecology2000;183(5):1176‐9. ">Ravasia 2000</a>), approximating the risk after spontaneous onset of labour. </p> <p>The observed increase in risk of uterine rupture following prostaglandin administration may reflect changes that are induced in the connective tissue of the uterine scar, thereby, weakening it. Equally, it could be reflective of the woman’s cervix being ‘unfavourable’ for labour (<a href="./references#CD009792-bbs2-0024" title="BujoldE , BlackwellSC , GauthierRJ . Cervical ripening with transcervical Foley catheter and the risk of uterine rupture. Obstetrics &amp; Gynecology2004;103(1):18‐23. ">Bujold 2004</a>; <a href="./references#CD009792-bbs2-0038" title="KayaniSI , AlfirevicZ . Uterine rupture after induction of labour in women with previous caesarean section. BJOG: an international journal of obstetrics and gynaecology2005;112(4):451‐5. ">Kayani 2005</a>), which in turn has been recognised to be associated with adverse maternal and infant outcomes following the trial of labour (<a href="./references#CD009792-bbs2-0040" title="LandonMB , LeindeckerS , SpongCY , HauthJC , BloomS , VarnerMW , et al. The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. American Journal of Obstetrics and Gynecology2005;193(3 Pt 2):1016‐23. ">Landon 2005</a>). </p> <p>The use of oxytocin to induce labour in women who have had a prior caesarean birth is also associated with an increased risk of uterine rupture (36/10,000 women without the use of oxytocin compared with 87/10,000 women following oxytocin use) (<a href="./references#CD009792-bbs2-0040" title="LandonMB , LeindeckerS , SpongCY , HauthJC , BloomS , VarnerMW , et al. The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. American Journal of Obstetrics and Gynecology2005;193(3 Pt 2):1016‐23. ">Landon 2005</a>). </p> <p>Clinical practice guidelines vary worldwide in relation to induction of labour for women who have had a previous caesarean section. The Society of Obstetricians and Gynaecologists of Canada clinical practice guidelines state that prostaglandins E2 (PGE2) should only be used in exceptional circumstances, and after appropriate counselling on the risk of uterine rupture, recommending that a Foley catheter be used in these women (<a href="./references#CD009792-bbs2-0055" title="Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. Guidelines for vaginal birth after previous caesarean birth. Number 155 (Replaces guideline Number 147), February 2005. International Journal of Gynaecology &amp; Obstetrics2005;89(3):319‐31. ">SOGC 2005</a>). The UK National Institute for Clinical Excellence (NICE) guidelines do not make any explicit recommendations, but do not discourage the use of prostaglandin (<a href="./references#CD009792-bbs2-0052" title="National Collaborating Centre for Women’s and Children’s Health. Induction of Labour. Clinical Guideline no 70. London: RCOG press, 2008. ">RCOG 2008</a>). In contrast, practice guidelines issued by the American College of Obstetricians and Gynaecologists state that the use of prostaglandins for cervical ripening or induction of labour in most women who have had a previous caesarean section should be discouraged (<a href="./references#CD009792-bbs2-0019" title="ACOG . Committee Opinion No 342: induction of labor for vaginal birth after cesarean delivery. Obstetrics &amp; Gynecology2006;108(2):465‐8. ">ACOG 2006</a>). </p> </section> <section id="CD009792-sec-0034"> <h3 class="title" id="CD009792-sec-0034">Why it is important to do this review</h3> <p>Cohort studies suggest that for women who have had a previous caesarean birth and require induction of labour in a subsequent pregnancy, there are potential benefits and harms associated with the induction of labour. These benefits and harms may vary considerably with the method used to induce labour. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009792-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009792-sec-0035"></div> <p>To assess the benefits and harms associated with different methods used to induce labour in women who have had a previous caesarean birth and require induction of labour in a subsequent pregnancy. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009792-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009792-sec-0036"></div> <section id="CD009792-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009792-sec-0038"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (with reported data for women and infants) comparing any method of term cervical ripening or labour induction, with placebo/no treatment or other methods, not including the comparison of induction of labour versus expectant management. Quasi‐randomised controlled trials, cluster‐randomised trials, and those presented only as an abstract were eligible for inclusion. Cross‐over trials are not relevant to this intervention and were not eligible for inclusion. </p> </section> <section id="CD009792-sec-0039"> <h4 class="title">Types of participants</h4> <p>Pregnant women with a live fetus, who have had a previous caesarean section, requiring induction of labour in the third trimester of pregnancy. </p> </section> <section id="CD009792-sec-0040"> <h4 class="title">Types of interventions</h4> <p>All methods of cervical ripening or labour induction including: prostaglandin medication (including oral or vaginal PGE2 and misoprostol); mifepristone; mechanical methods (including Foley catheters and double‐balloon catheters); oxytocin, or placebo compared with placebo or any other method were included. </p> </section> <section id="CD009792-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>Clinically relevant outcomes for trials of methods of cervical ripening/labour induction have been prespecified and published in the Cochrane generic protocol relating to induction of labour (<a href="./references#CD009792-bbs2-0036" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074.pub2] ">Hofmeyr 2009</a>). </p> <section id="CD009792-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>1. Vaginal delivery not achieved within 24 hours (or period specified by trial authors)<br/> 2. Uterine hyperstimulation with fetal heart rate (FHR) changes<br/> 3. Caesarean section<br/> 4. Serious neonatal morbidity or perinatal death (e.g. seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood)<br/> 5. Serious maternal morbidity or death (e.g. uterine rupture, admission to intensive care unit, septicaemia) </p> </section> <section id="CD009792-sec-0043"> <h5 class="title">Secondary outcomes</h5> <section id="CD009792-sec-0044"> <h6 class="title">Measures of effectiveness</h6> <p>6. Cervix unfavourable/unchanged after 12 to 24 hours<br/> 7. Oxytocin augmentation </p> </section> <section id="CD009792-sec-0045"> <h6 class="title">Complications</h6> <p>8. Uterine hyperstimulation without FHR changes<br/> 9. Uterine rupture<br/> 10. Epidural analgesia<br/> 11. Instrumental vaginal delivery<br/> 12. Meconium‐stained liquor<br/> 13. Apgar score less than 7 at five minutes<br/> 14. Neonatal intensive care unit admission<br/> 15. Neonatal encephalopathy<br/> 16. Perinatal death<br/> 17. Disability in childhood<br/> 18. Neonatal infection<br/> 19. Neonatal antibiotics<br/> 20. Maternal side‐effects (all)<br/> 21. Maternal nausea<br/> 22. Maternal vomiting<br/> 23. Maternal diarrhoea<br/> 24. Other maternal side‐effects<br/> 25. Postpartum haemorrhage<br/> 26. Chorioamnionitis<br/> 27. Endometritis<br/> 28. Maternal antibiotics<br/> 29. Serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture)<br/> 30. Maternal death </p> </section> <section id="CD009792-sec-0046"> <h6 class="title">Measures of satisfaction</h6> <p>31. Woman not satisfied<br/> 32. Caregiver not satisfied </p> <p>'Uterine rupture' includes all clinically significant ruptures of unscarred or scarred uteri. Trivial scar dehiscence noted incidentally at the time of surgery was excluded.<br/> <br/> In the reviews, we use the term 'uterine hyperstimulation without FHR changes' to include uterine tachysystole (more than five contractions per 10 minutes for at least 20 minutes) and uterine hypersystole/hypertonus (a contraction lasting at least two minutes) and 'uterine hyperstimulation with FHR changes' to denote uterine hyperstimulation syndrome (tachysystole or hypersystole with FHR changes such as persistent decelerations, tachycardia or decreased short‐term variability). </p> <p>Outcomes are included in the analysis if data are available according to treatment allocation and reasonable measures were taken to minimise observer bias. While all the above outcomes were sought, only outcomes with available data appear in the analysis tables. Data not pre‐stated were extracted and reported as not pre‐specified. </p> </section> </section> </section> </section> <section id="CD009792-sec-0047"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD009792-sec-0048"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (31 August 2016). </p> <p>The Register is a database containing over 23,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<i><b>Specialized Register</b> </i> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD009792-list-0001"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<a href="./references#CD009792-bbs1-0001" title="">Included studies</a>; <a href="./references#CD009792-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD009792-bbs1-0003" title="">Ongoing studies</a>). </p> </section> <section id="CD009792-sec-0049"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD009792-sec-0050"> <h3 class="title" id="CD009792-sec-0050">Data collection and analysis</h3> <p>For methods used in the previous version of this review, see <a href="./references#CD009792-bbs2-0058" title="JozwiakM , DoddJM . Methods of term labour induction for women with a previous caesarean section. Cochrane Database of Systematic Reviews2013, Issue 3. [DOI: 10.1002/14651858.CD009792.pub2] ">Jozwiak 2013</a>. </p> <p>For this update, we used the following methods for assessing the 12 reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD009792-sec-0051"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted the third review author. </p> </section> <section id="CD009792-sec-0052"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager 5 (RevMan 5) software (<a href="./references#CD009792-bbs2-0053" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD009792-sec-0053"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009792-bbs2-0034" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD009792-sec-0054"> <h5 class="title">1. Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD009792-list-0002"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random‐number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009792-sec-0055"> <h5 class="title">2. Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD009792-list-0003"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively‐numbered, sealed, opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009792-sec-0056"> <h5 class="title">3.1. Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD009792-list-0004"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD009792-sec-0057"> <h5 class="title">3.2. Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD009792-list-0005"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009792-sec-0058"> <h5 class="title">4. Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses that we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD009792-list-0006"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as‐treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009792-sec-0059"> <h5 class="title">5. Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD009792-list-0007"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009792-sec-0060"> <h5 class="title">6. Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD009792-sec-0061"> <h5 class="title">7. Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of interventions</i> (<a href="./references#CD009792-bbs2-0034" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses ‐ see <a href="#CD009792-sec-0075">Sensitivity analysis</a>. </p> </section> <section id="CD009792-sec-0062"> <h5 class="title">Assessing the quality of the evidence using GRADE</h5> <p>For this update we have assessed the quality of the evidence using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the quality of the body of evidence relating to the following outcomes for the main comparisons. </p> <p> <ol id="CD009792-list-0008"> <li> <p>Vaginal delivery not achieved within 24 hours (or period specified by trial authors)</p> </li> <li> <p>Uterine hyperstimulation with fetal heart rate changes</p> </li> <li> <p>Caesarean section</p> </li> <li> <p>Serious neonatal morbidity or perinatal death (e.g. seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood) </p> </li> <li> <p>Serious maternal morbidity or death (e.g. uterine rupture, admission to intensive care unit, septicaemia) </p> </li> </ol> </p> <p>We used GRADEpro Guideline Development Tool (<a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro GDT</a>) to import data from RevMan 5 (<a href="./references#CD009792-bbs2-0053" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create 'Summary of findings' tables. We produced a summary of the intervention effect and a measure of quality for each of the above outcomes using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD009792-sec-0063"> <h4 class="title">Measures of treatment effect</h4> <section id="CD009792-sec-0064"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD009792-sec-0065"> <h5 class="title">Continuous data</h5> <p>We used the mean difference if outcomes were measured in the same way between trials. We used the standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD009792-sec-0066"> <h4 class="title">Unit of analysis issues</h4> <section id="CD009792-sec-0067"> <h5 class="title">Cluster‐randomised trials</h5> <p>Our searches did not identify any cluster‐randomised trials for inclusion in the analyses. In future updates, if we identify any cluster‐randomised controlled trials we will include them in our analyses along with the individually randomised trials. We will adjust their sample sizes using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009792-bbs2-0035" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>) using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> </section> <section id="CD009792-sec-0068"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are inappropriate for this intervention.</p> </section> <section id="CD009792-sec-0069"> <h5 class="title">Multi‐armed trials</h5> <p>We identified one multi‐arm trial, however only two arms were reported in the study publication. We contacted the trial authors to request data on the other arms but did not receive a reply. If we had received these data, we would have combined all relevant experimental intervention groups of the study into a single group and all relevant control intervention groups into a single control group when we analysed the data. If we had considered one of the arms irrelevant, we would have excluded it from analysis. </p> </section> </section> <section id="CD009792-sec-0070"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. In future updates, if we include more eligible studies, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, that is, we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD009792-sec-0071"> <h4 class="title">Assessment of heterogeneity</h4> <p>We did not combine data from the included studies. In future updates we will assess statistical heterogeneity in each meta‐analysis using the Tau², I² (<a href="./references#CD009792-bbs2-0033" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>) and Chi² statistics (<a href="./references#CD009792-bbs2-0028" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). We will regard heterogeneity as substantial if I² is greater than 30% and either Tau² is greater than zero, or there is a low P value (less than 0.10) in the Chi² test for heterogeneity. If we identify substantial heterogeneity (above 30%), we will explore it by pre‐specified subgroup analysis. </p> </section> <section id="CD009792-sec-0072"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD009792-sec-0073"> <h4 class="title">Data synthesis</h4> <p>Meta‐analysis was not possible because the studies compared different methods of labour induction. In future updates we will carry out statistical analysis using RevMan 5 software (<a href="./references#CD009792-bbs2-0053" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will use fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: that is, where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there is clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity is detected, we will use random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials is considered clinically meaningful. The random‐effects summary will be treated as the average range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials. If we use random‐effects analyses, we will present the results as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD009792-sec-0074"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In future updates, if we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will considered whether an overall summary is meaningful, and if it is, we will use a random‐effects analysis to produce it. </p> <p>We plan to carry out the following subgroup analyses:</p> <p> <ol id="CD009792-list-0009"> <li> <p>previous vaginal birth (yes versus no);</p> </li> <li> <p>number of previous caesarean births (one versus two versus three or more);</p> </li> <li> <p>indication for previous caesarean birth(s) (failure to progress versus fetal distress versus other); </p> </li> <li> <p>indication for labour induction (hypertensive disorders versus post‐term pregnancy versus intrauterine growth restriction versus maternal disease versus other indication); </p> </li> <li> <p>favourability of the cervix (favourable versus unfavourable);</p> </li> <li> <p>status of membranes (ruptured versus unruptured);</p> </li> <li> <p>gestational age (37 to 40 weeks versus 40 to 41 weeks versus more than 41 weeks).</p> </li> </ol> </p> <p>We will restrict planned subgroup analysis to the primary outcomes.</p> <p>We will assess subgroup differences by interaction tests available within RevMan 5 (<a href="./references#CD009792-bbs2-0053" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD009792-sec-0075"> <h4 class="title">Sensitivity analysis</h4> <p>In future updates, we will carry out sensitivity analyses, where appropriate, to explore the effect of trial quality assessed by concealment of allocation, high attrition rates, or both, with poor‐quality studies being excluded from the analyses in order to assess whether this makes any difference to the overall result. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009792-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009792-sec-0076"></div> <section id="CD009792-sec-0077"> <h3 class="title">Description of studies</h3> <section id="CD009792-sec-0078"> <h4 class="title">Results of the search</h4> <p>The updated search of Cochrane Pregnancy and Childbirth's Trials Register retrieved 12 reports (see <a href="#CD009792-fig-0001">Figure 1</a>). We included six new studies (10 reports) (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>). One new study was excluded (<a href="./references#CD009792-bbs2-0014" title="RamyaV , GhoseS , PallaveeP . Membrane sweeping for vaginal birth after caesarean section and its outcome ‐a comparative study. Journal of Clinical and Diagnostic Research2015;9(8):QC01‐3. ">Ramya 2015</a>) and one study is ongoing (<a href="./references#CD009792-bbs2-0018" title="NCT02196103 . Management of labor in patients with previous cesarian section and premature rupture of membranes who desire TOLAC: comparison between the use of standard expectant management and the double‐balloon catheter device. A prospective randomized study. clinicaltrials.gov/ct2/show/NCT02196103 Date first received: 15 July 2014. ">NCT02196103</a>). </p> <div class="figure" id="CD009792-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD009792-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD009792-sec-0079"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD009792-sec-0139" title="">Characteristics of included studies</a>. </p> <p>Altogether we included eight studies in the review (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). A subset of the women who participated in <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> had a prior caesarean section, and it was only this subset of results that we included in our review. Only data for women who were 37 weeks' gestation or more in <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a> were included in this review (unpublished data supplied by the trial author). </p> <section id="CD009792-sec-0080"> <h5 class="title">Design</h5> <p>Seven of the included studies were two‐arm randomised controlled trials (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), one was a four‐arm randomised controlled trial however only two arms were reported in the publications (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>). Trials compared different methods of labour induction. </p> </section> <section id="CD009792-sec-0081"> <h5 class="title">Sample sizes</h5> <p>The studies range in size from 26 women (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>) to 200 women (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>). The total number of women contributing data to the review is 707. </p> </section> <section id="CD009792-sec-0082"> <h5 class="title">Setting</h5> <p>Three studies took place in India (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>), one in Saudi Arabia (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>), one in Denmark (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>), one in Egypt (<a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>), one in the UK (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), and one in the USA (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). </p> </section> <section id="CD009792-sec-0083"> <h5 class="title">Participants</h5> <p>All participants were women with a prior caesarean section. In <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> this was a subgroup within a trial of all women undergoing induction. </p> <p>All studies looked at induction at term, or approaching term. The gestational age at which women were eligible varied: in <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> women were 40 weeks' gestation, in <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>, <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a> and <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a> they were at least 37 weeks gestational age, and in <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a> they were 37 to 42 weeks' gestation. The inclusion criteria in <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a> is from 28 weeks gestational age. The gestational age of women who took part is not reported, although it states that the majority of women were between 38 and 40 weeks. In personal communication, the trial author reported that 26 out of 30 women in the Foley catheter group, and 27 out of 30 in the oxytocin group were 37 weeks' gestation or more, and provided data for this subgroup of women. <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> does not state a specific gestational age among the inclusion criteria. In the whole study the earliest gestational age was 32 + 5, however this information is not given in the published report for the subgroup of women with a prior caesarean. In personal communication, the trial author reported that all women with a prior caesarean were 37 weeks' gestation or more. The gestational age for included women is not stated in <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>. </p> <p>The indications for induction of labour varied between studies. <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a> included only women with post‐term pregnancy or pre‐eclampsia. <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> included only women with a post‐term pregnancy (defined by the trialists as from 40 weeks five days). <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>, <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>, <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>, <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>, <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a> and <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> used broad criteria for induction, including post‐term pregnancy, pre‐eclampsia or hypertension, gestational diabetes mellitus, oligohydramnios and intrauterine growth restriction. </p> <p>Seven studies specified cephalic presentation in the inclusion criteria (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). Seven studies included only women with a singleton pregnancy (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> did not exclude multiple pregnancies, however there were none in the subgroup of women with a previous caesarean section. Six studies specified that women could participate if they had had a previous low transverse or lower segment caesarean section (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> included women with one prior caesarean, but found that verifying the type of incision was "often impossible in our population", and <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> did not report on the number or nature of prior caesarean(s). </p> <p><a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>, <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>, <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a> and <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a> specified in their inclusion criteria that membranes had to be unruptured, as did the previous trial cited by <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> as having similar inclusion and exclusion criteria to this study (<a href="./references#CD009792-bbs2-0056" title="WingDA , PaulRH . A comparison of differing dosing regimens of vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1996;175:158‐64. ">Wing 1996</a>). <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a> and <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> excluded women with premature rupture of membranes from their studies, and <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a> did not describe the status of membranes for women to be included in the trial. </p> <p>The inclusion criteria of studies specified Bishop scores of less than or equal to seven (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>), less than or equal to six (<a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>), less than six (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>), less than five (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>), less than or equal to four (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), and modified Bishop score less than nine (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> did not specify. </p> <p>No information was reported on the indication for the previous caesarean section, or whether women had had a previous vaginal birth, in <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>, <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>, <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>, <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a> and <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>. In <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>, women whose only previous pregnancy was delivered by caesarean section were included, so no women had had a prior vaginal birth. The indications for previous caesarean sections are listed in a table in the report. <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> required that women had not had a vaginal birth since their caesarean section. Some women in <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a> had had more than one previous pregnancy (seven out of 70 in the 30 mL group, four out of 70 in the 80 mL group), however it does not report whether these previous births were caesarean or vaginal deliveries. <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a> reports that 56 out of 100 women in the tablet group and 62 out of 100 women in the pessary group had had a prior vaginal delivery, in addition to their previous caesarean section. </p> </section> <section id="CD009792-sec-0084"> <h5 class="title">Interventions</h5> <p>Three studies made a comparison with oxytocin: vaginal PGE2 (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), vaginal misoprostol (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), and Foley catheter (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>). Two additional studies made a comparison with Foley catheter: oral mifepristone (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>), and vaginal isosorbide mononitrate (<a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>). One study compared double‐balloon catheter with vaginal PGE2 (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>), one compared 30 mL Foley catheter with 80 mL Foley catheter (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>), and one compared vaginal PGE2 tablet with vaginal PGE2 pessary (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>). </p> <p>The dose of intravenous oxytocin was started at 1 mU/minute and increased if contractions were not frequent after one hour in <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>, "per a standardized infusion protocol" in <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>, and in <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>, the dose was not reported. Amniotomy was done at the start of oxytocin administration <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a> and <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>, but is not reported in <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>. PGE2 was administered as a 2.5 mg vaginal pessary (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), or 3 mg vaginal tablet (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>). The dose of misoprostol was 25 μg intravaginally every six hours to a maximum of four doses (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). The Foley catheter balloon was inserted to the endocervix and inflated with 30 mL of sterile saline (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>) or inserted into the cervix beyond the internal os and inflated with 80 mL or 30 mL of sterile water (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>) or 50 mL to 60 mL of normal saline (<a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>). The double‐balloon catheter was inflated with 80 mL of saline in the uterine balloon and 80 mL of saline in the cervicovaginal balloon (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>). Women received a dose of 400 mg mifepristone orally (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>). Women received either 1.5 mg PGE2 (dinoprostone) vaginal tablet into the posterior vaginal fornix for a maximum of three doses with six‐hourly intervals, or a single dose of PGE2 (dinoprostone) 10 mg sustained‐release vaginal pessary into the posterior vaginal fornix (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>). </p> </section> <section id="CD009792-sec-0085"> <h5 class="title">Outcomes</h5> <p>Three studies reported very few of our prespecified outcomes or did not report them in a form that could be included in the review (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). Perinatal outcomes were especially scarce. <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> reported only uterine rupture, and <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> reported oxytocin augmentation and uterine rupture. Caesarean section and neonatal unit admission were the only prespecified outcomes reported for the subgroup of women with a previous caesarean in <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>. </p> <p>Five studies reported more of our prespecified outcomes (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), including the primary outcomes: any delivery not achieved within 24 hours (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>), uterine hyperstimulation with FHR changes (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>), caesarean section (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), serious neonatal morbidity or perinatal death (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), and serious maternal morbidity or death (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). In several studies (e.g. <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>) the composite outcomes were not reported, but individual elements of them were, for example, perinatal death, uterine rupture, and maternal admission to intensive care unit. </p> </section> </section> <section id="CD009792-sec-0086"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD009792-sec-0140" title="">Characteristics of excluded studies</a>. </p> <p>We excluded nine studies (<a href="./references#CD009792-bbs2-0009" title="ArraztoaJA , JensenL , ClaveroM , CastilloH . Delivery conduction in patients with cicatrix of a prior Cesarean section. Pilot study. Revista Chilena de Obstetricia y Ginecologia1994;59(2):95‐100; discussion 100‐1. ">Arraztoa 1994</a>; <a href="./references#CD009792-bbs2-0010" title="Ben‐AroyaZ , HallakM , SegalD , FrigerM , KatzM , MazorM . Ripening of the uterine cervix in post cesarean parturient: PGE2 vs intracervical Foley catheter. American Journal of Obstetrics and Gynecology2001;184(1):S117. ">Ben‐Aroya 2001</a>; <a href="./references#CD009792-bbs2-0011" title="HamdanM , SidhuK , SabirN , OmarSZ , TanPC . Serial membrane sweeping at term in planned vaginal birth after cesarean: a randomized controlled trial. Obstetrics &amp; Gynecology2009;114(4):745‐51. ">Hamdan 2009</a>; <a href="./references#CD009792-bbs2-0012" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101:501‐3. ">Lelaidier 1994</a>; <a href="./references#CD009792-bbs2-0013" title="MoralesWJ , LazarAJ . Expectant management of rupture of membranes at term. Southern Medical Journal1986;79:955‐8. ">Morales 1986</a>; <a href="./references#CD009792-bbs2-0014" title="RamyaV , GhoseS , PallaveeP . Membrane sweeping for vaginal birth after caesarean section and its outcome ‐a comparative study. Journal of Clinical and Diagnostic Research2015;9(8):QC01‐3. ">Ramya 2015</a>; <a href="./references#CD009792-bbs2-0015" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics &amp; Gynecology1999;94(2):250‐4. ">Rayburn 1999</a>; <a href="./references#CD009792-bbs2-0016" title="ManleyJ , NguyenL , ShlossmanP , ColmorgenG , SciscioneA . A randomized prospective comparison of the intracervical Foley bulb to intravaginal misoprostol (cytotec) for preinduction cervical ripening. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S76. SciscioneAC , NguyenL , ManleyJ , PollockM , MaasB , ColmorgenG . A randomized comparison of transcervical Foley catheter to intravaginal misoprostol for preinduction cervical ripening. Obstetrics &amp; Gynecology2001;97(4):603‐7. ">Sciscione 2001</a>; <a href="./references#CD009792-bbs2-0017" title="SpallicciMD , ChieaMA , SingerJM , AlbuquerquePB , BittarRE , ZugaibM . Use of hyaluronidase for cervical ripening: a randomized trial. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(1):46‐50. SpallicciMDB , BittarRE . Randomized double blind study of ripening the cervix with hyaluronidase in term gestations [Estudo clinico aleatorizado com grupo controle e mascaramento duplo da maturacao do colo uterino pela hialuronidase em gestacoes a termo]. Revista Brasileira de Ginecologia e Obstetricia2003;25(1):67. ">Spallicci 2007</a>). </p> <p>The studies by <a href="./references#CD009792-bbs2-0009" title="ArraztoaJA , JensenL , ClaveroM , CastilloH . Delivery conduction in patients with cicatrix of a prior Cesarean section. Pilot study. Revista Chilena de Obstetricia y Ginecologia1994;59(2):95‐100; discussion 100‐1. ">Arraztoa 1994</a>, <a href="./references#CD009792-bbs2-0013" title="MoralesWJ , LazarAJ . Expectant management of rupture of membranes at term. Southern Medical Journal1986;79:955‐8. ">Morales 1986</a> and <a href="./references#CD009792-bbs2-0015" title="GittensL , SchenkelC , StrassbergS , ApuzzioJ . Vaginal birth after cesarean section: comparison of outpatient use of prostaglandin gel to expectant management. American Journal of Obstetrics and Gynecology1996;174(1 Pt 2):354. RayburnW , LucasM , GittensL , GoodwinTM , BaxiL , GallS , et al. Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E2 gel with expectant management. Primary Care Update for Ob/Gyns1998;5(4):182‐3. RayburnWF , GittensLN , LucasMJ , GallSA , MartinME . Weekly administration of prostaglandin e2 gel compared with expectant management in women with previous cesareans Prepidil gel study group. Obstetrics &amp; Gynecology1999;94(2):250‐4. ">Rayburn 1999</a> compared a pharmacological method of induction of labour with ongoing expectant management of the pregnancy. The <a href="./references#CD009792-bbs2-0010" title="Ben‐AroyaZ , HallakM , SegalD , FrigerM , KatzM , MazorM . Ripening of the uterine cervix in post cesarean parturient: PGE2 vs intracervical Foley catheter. American Journal of Obstetrics and Gynecology2001;184(1):S117. ">Ben‐Aroya 2001</a> study did not involve a randomised comparison, while <a href="./references#CD009792-bbs2-0011" title="HamdanM , SidhuK , SabirN , OmarSZ , TanPC . Serial membrane sweeping at term in planned vaginal birth after cesarean: a randomized controlled trial. Obstetrics &amp; Gynecology2009;114(4):745‐51. ">Hamdan 2009</a> and <a href="./references#CD009792-bbs2-0014" title="RamyaV , GhoseS , PallaveeP . Membrane sweeping for vaginal birth after caesarean section and its outcome ‐a comparative study. Journal of Clinical and Diagnostic Research2015;9(8):QC01‐3. ">Ramya 2015</a> compared weekly membrane sweeping with weekly vaginal examination, in women who did not require induction of labour. </p> <p>The <a href="./references#CD009792-bbs2-0012" title="LelaidierC , BatonC , BeniflaJL , FernandezH , BourgetP , FrydmanR . Mifepristone for labour induction after previous caesarean section. British Journal of Obstetrics and Gynaecology1994;101:501‐3. ">Lelaidier 1994</a> study compared mifepristone with placebo as a pre‐induction agent, followed by vaginal prostaglandin induction in all women after an observation period of four days. <a href="./references#CD009792-bbs2-0017" title="SpallicciMD , ChieaMA , SingerJM , AlbuquerquePB , BittarRE , ZugaibM . Use of hyaluronidase for cervical ripening: a randomized trial. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2007;130(1):46‐50. SpallicciMDB , BittarRE . Randomized double blind study of ripening the cervix with hyaluronidase in term gestations [Estudo clinico aleatorizado com grupo controle e mascaramento duplo da maturacao do colo uterino pela hialuronidase em gestacoes a termo]. Revista Brasileira de Ginecologia e Obstetricia2003;25(1):67. ">Spallicci 2007</a> compared hyaluronidase with placebo in women with a prior caesarean birth at term, who did not require induction of labour. <a href="./references#CD009792-bbs2-0016" title="ManleyJ , NguyenL , ShlossmanP , ColmorgenG , SciscioneA . A randomized prospective comparison of the intracervical Foley bulb to intravaginal misoprostol (cytotec) for preinduction cervical ripening. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S76. SciscioneAC , NguyenL , ManleyJ , PollockM , MaasB , ColmorgenG . A randomized comparison of transcervical Foley catheter to intravaginal misoprostol for preinduction cervical ripening. Obstetrics &amp; Gynecology2001;97(4):603‐7. ">Sciscione 2001</a> compared transcervical Foley catheter with misoprostol to induce labour in women with a prior caesarean birth. However, the trial inclusion criteria were modified to exclude women with a prior caesarean birth, following the occurrence of a uterine rupture in the misoprostol group. </p> </section> </section> <section id="CD009792-sec-0087"> <h3 class="title">Risk of bias in included studies</h3> <p>Assessment of the methodological quality of the included studies was based on risk of bias in relation to selection bias (method of randomisation and allocation concealment), performance bias, detection bias, attrition bias (loss of participants from the analyses) and reporting bias. Summaries of 'Risk of bias' assessments for each study, and for included trials overall, are set out in <a href="#CD009792-fig-0002">Figure 2</a> and <a href="#CD009792-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009792-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD009792-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD009792-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009792-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD009792-sec-0088"> <h4 class="title">Allocation (selection bias)</h4> <section id="CD009792-sec-0089"> <h5 class="title">Generation of the randomisation sequence</h5> <p>Three studies reported using a computer‐generated random sequence (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>) and one used Tippets random number table (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>), which we judged were at low risk of bias. The method of generating the randomisation sequence was not described in two studies (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), which we judged to be unclear risk of bias. <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> reported an intention to use computer‐generated randomisation in the study protocol, but this was not reported in the study report. We contacted the study author to clarify the method, but no response has been received, so their method was judged to be unclear risk of bias. <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a> described using "predetermined code envelope" which we also judged to be at unclear risk of bias. </p> </section> <section id="CD009792-sec-0090"> <h5 class="title">Allocation concealment</h5> <p>In three of the studies, the method for concealing group allocation at the point of randomisation was at low risk of bias: randomised by a central telephone automatic voice‐response system (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>), and sealed, opaque envelopes (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). The method for concealing group allocation was not described in <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>, <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>, <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a> or <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>, which we judged to be at unclear risk of bias. <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> reported an intention to use "sequentially numbered, sealed, opaque envelopes" in the study protocol, but this was not described in the study report, and enquiries to clarify the method were not answered, so we decided it was at unclear risk of bias. </p> </section> </section> <section id="CD009792-sec-0091"> <h4 class="title">Blinding (performance bias and detection bias)</h4> <p><a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a> is the only study that reported any attempt to blind women or health professionals to group allocation. In this study, the decision to perform caesarean section was left to the discretion of an obstetrician who was unaware of group allocation. Women were unlikely to be aware of how much sterile water was in the Foley catheter, despite the personnel responsible for inserting and removing the catheter knowing. Therefore blinding was not perfect, but the bias was minimised and we judged it to be low risk of bias. </p> <p>No other studies were blinded (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). It was not feasible to blind women or health professionals to most of these comparisons. This may have had an effect on other treatment decisions. All included studies have consequently been assessed as high risk of bias due to lack of blinding. It might have been possible to blind outcome assessors, but this was not described in any studies, so they were all judged to be at unclear risk of bias. </p> </section> <section id="CD009792-sec-0092"> <h4 class="title">Incomplete outcome data (attrition bias)</h4> <p>Five studies were judged to be at low risk of attrition bias. All women appear to be accounted for and there is no mention of women dropping out of the study in <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>, <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>, <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>, <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a> and <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>. </p> <p>Two studies had unclear risk of attrition bias. In <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>, all women recruited appear to be accounted for in the results. However, the omission of two arms of the study may suggest bias. There is insufficient information in <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> to judge whether all women were accounted for. </p> <p>One study was at high risk of bias. Women in <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> who went into spontaneous labour before induction, who were not in labour after 48 hours, or who had been coded as "VBAC" (vaginal birth after caesarean section) in error were classed as ‘failure’ and excluded from the results. There were 13 women randomised to each group, however results for only 10 are reported in the publication, and in correspondence from the study author additional 'failures' were identified. In the Minprostin group, two women began labour before induction, three were not in labour after 48 hours, and one was wrongly coded as VBAC. In the balloon group, three began labour before induction, one was not VBAC and 0 were not in labour after 48 hours. Unfortunately, despite additional information from the study authors, there were still missing data on outcomes, and we were unable to add the excluded women in an intention‐to‐treat analysis. </p> </section> <section id="CD009792-sec-0093"> <h4 class="title">Selective reporting (reporting bias)</h4> <p>Two studies were judged to be at high risk of reporting bias. The protocol for <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> describes a four‐arm study, but only two arms were reported in the publication. The abstracts from which it was assessed do not report any prespecified neonatal outcomes, and report only two arms of the four comparison groups set out in the protocol. No response was received from the authors when additional details were requested. In <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>, uterine rupture is the only outcome reported. It is likely that other outcomes were prespecified and these are not reported. </p> <p>Four studies were at unclear risk of reporting bias: <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>, <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a> and <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a> were assessed from published reports, without protocols available. It is unclear whether all prespecified outcomes were reported in these studies. Several secondary outcomes prespecified in the protocol for <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a> were not reported in the published study report. In <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> the subset of participants with a previous VBAC were not the primary focus of this study, so few outcomes are reported for these women. </p> <p>One study was at low risk of reporting bias: <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a> was assessed from a published report with no protocol available, however outcomes were comprehensively reported. </p> </section> <section id="CD009792-sec-0094"> <h4 class="title">Other potential sources of bias</h4> <p>Five studies were at low risk: the groups were comparable at baseline, and no other potential sources of bias were identified (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). </p> <p>Three studies were considered to be at high risk of other bias: the inconsistencies between the study protocol and published report for <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> suggest that this study is at high risk of other bias. In <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> the primary endpoints of the full study are reported by both intention‐to‐treat and per‐protocol analyses, indicating that a large proportion of women did not receive the allocated treatment. <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> was stopped prematurely due to safety concerns. </p> </section> </section> <section id="CD009792-sec-0095"> <h3 class="title" id="CD009792-sec-0095">Effects of interventions</h3> <p>See: <a href="./full#CD009792-tbl-0001"><b>Summary of findings for the main comparison</b> Vaginal PGE2 versus intravenous (IV) oxytocin</a>; <a href="./full#CD009792-tbl-0002"><b>Summary of findings 2</b> Vaginal misoprostol versus intravenous (IV) oxytocin</a>; <a href="./full#CD009792-tbl-0003"><b>Summary of findings 3</b> Foley catheter versus intravenous (IV) oxytocin</a>; <a href="./full#CD009792-tbl-0004"><b>Summary of findings 4</b> Double‐balloon catheter versus vaginal PGE2</a>; <a href="./full#CD009792-tbl-0005"><b>Summary of findings 5</b> Oral mifepristone versus Foley catheter</a>; <a href="./full#CD009792-tbl-0006"><b>Summary of findings 6</b> Vaginal isosorbide mononitrate versus Foley catheter</a>; <a href="./full#CD009792-tbl-0007"><b>Summary of findings 7</b> 80 mL versus 30 mL Foley catheter</a>; <a href="./full#CD009792-tbl-0008"><b>Summary of findings 8</b> Vaginal PGE2 pessary versus vaginal PGE2 tablet</a> </p> <p>We did not combine data from the six included studies because they used different methods of induction of labour, so we did not consider meta‐analysis appropriate. </p> <section id="CD009792-sec-0096"> <h4 class="title">1. Vaginal PGE2 inserts versus intravenous oxytocin</h4> <p>A single study involving 42 women compared vaginal PGE2 with intravenous oxytocin for induction of labour (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). See <a href="./full#CD009792-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD009792-sec-0097"> <h5 class="title">Primary outcomes</h5> <p>There were no differences identified between the two treatment groups for <b>caesarean section</b> (risk ratio (RR) 0.67, 95% confidence interval (CI) 0.22 to 2.03, one study, 42 women, evidence graded low, <a href="./references#CD009792-fig-0004" title="">Analysis 1.1</a>). There was only one event for <b>serious neonatal morbidity or perinatal death</b> and <b>serious maternal morbidity or death</b>, so the analysis of differences between groups was not meaningful (one study, 42 women<i>,</i> evidence graded low, <a href="./references#CD009792-fig-0005" title="">Analysis 1.2</a>; one study, 42 women, evidence graded low<i>,</i><a href="./references#CD009792-fig-0006" title="">Analysis 1.3</a>). </p> <p>The study did not report the following primary/GRADE outcomes: <b>vaginal delivery not achieved within 24 hours,</b> and<b>uterine hyperstimulation with fetal heart rate (FHR) changes</b>. </p> </section> <section id="CD009792-sec-0098"> <h5 class="title">Secondary outcomes</h5> <p>One woman was identified as having a <b>uterine rupture</b> following prostaglandin administration, so the analysis is not meaningful (one study, 42 women, <a href="./references#CD009792-fig-0007" title="">Analysis 1.4</a>). There were no differences identified in the secondary maternal or infant outcomes, including use of <b>epidural analgesia</b> (RR 1.42, 95% CI 0.93 to 2.17, one study, 42 women, <a href="./references#CD009792-fig-0008" title="">Analysis 1.5</a>), <b>instrumental vaginal delivery</b> (RR 1.25, 95% CI 0.39 to 4.02, one study, 42 women, <a href="./references#CD009792-fig-0009" title="">Analysis 1.6</a>), or <b>Apgar score of less than seven at five minutes</b> (no events, one study, 42 infants, <a href="./references#CD009792-fig-0010" title="">Analysis 1.7</a>). </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, oxytocin augmentation, uterine hyperstimulation without FHR changes, meconium‐stained liquor, neonatal intensive care unit admission, neonatal encephalopathy, perinatal death, disability in childhood, neonatal infection, neonatal antibiotics, maternal side‐effects (all), maternal nausea, maternal vomiting, maternal diarrhoea, other maternal side‐effects, postpartum haemorrhage, chorioamnionitis, endometritis, maternal antibiotics, serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture), maternal death, woman not satisfied, and caregiver not satisfied. </p> </section> </section> <section id="CD009792-sec-0099"> <h4 class="title">2. Vaginal misoprostol versus intravenous oxytocin</h4> <p>There was one study comparing vaginal misoprostol and intravenous oxytocin included in the review (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). No GRADE outcomes were reported. See <a href="./full#CD009792-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD009792-sec-0100"> <h5 class="title">Primary outcomes</h5> <p>This trial was stopped following recruitment and randomisation of 38 women (17 women misoprostol group; 21 women oxytocin group) and no primary outcomes or GRADE outcomes were reported (<b>vaginal delivery not achieved within 24 hours</b> , <b>uterine hyperstimulation with FHR changes</b> , <b>caesarean section</b> , <b>serious neonatal morbidity or perinatal death</b> , and <b>serious maternal morbidity or death</b>). </p> </section> <section id="CD009792-sec-0101"> <h5 class="title">Secondary outcomes</h5> <p>The only outcome reported was <b>uterine rupture</b>, which occurred in one woman in the misoprostol group (RR 3.67, 95% CI 0.16 to 84.66, one study, 38 women, <a href="./references#CD009792-fig-0011" title="">Analysis 2.1</a>). One woman in the misoprostol group also experienced uterine dehiscence. </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, oxytocin augmentation, uterine hyperstimulation without FHR changes, epidural analgesia, instrumental vaginal delivery, meconium‐stained liquor, Apgar score less than seven at five minutes, neonatal intensive care unit admission, neonatal encephalopathy, perinatal death, disability in childhood, neonatal infection, neonatal antibiotics, maternal side‐effects (all), maternal nausea, maternal vomiting, maternal diarrhoea, other maternal side‐effects, postpartum haemorrhage, chorioamnionitis, endometritis, maternal antibiotics, serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture), maternal death, woman not satisfied, and caregiver not satisfied. </p> </section> </section> <section id="CD009792-sec-0102"> <h4 class="title">3. Foley catheter versus intravenous oxytocin</h4> <p>One study comparing Foley catheter with intravenous oxytocin was included (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>). The study author supplied unpublished data for the women who were 37 weeks' gestation or more (53 of the 60 women who participated). See <a href="./full#CD009792-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD009792-sec-0103"> <h5 class="title">Primary outcomes</h5> <p>There was no difference between oxytocin and Foley catheter in the number of women who <b>delivered within 24 hours</b> (RR 1.47, 95% CI 0.89 to 2.44, one study, 53 women, evidence graded low, <a href="./references#CD009792-fig-0012" title="">Analysis 3.1</a>), <b>uterine hyperstimulation with FHR changes</b> (RR 3.11, 95% CI 0.13 to 73.09, one study, 53 women, evidence graded low, <a href="./references#CD009792-fig-0013" title="">Analysis 3.2</a>), or the number of women requiring a <b>caesarean section</b> (RR 0.93, 95% CI 0.45 to 1.92, one study, 53 women, evidence graded low<i>,</i><a href="./references#CD009792-fig-0014" title="">Analysis 3.3</a>). </p> <p>The study did not report the following primary/GRADE composite outcomes: <b>serious neonatal morbidity or perinatal death</b> , and <b>serious maternal morbidity or death</b>. </p> </section> <section id="CD009792-sec-0104"> <h5 class="title">Secondary outcomes</h5> <p>There was no difference between the groups in the number of women requiring <b>oxytocin augmentation</b> (RR 1.04, 95% CI 0.81 to 1.32, one study, 53 women, <a href="./references#CD009792-fig-0015" title="">Analysis 3.4</a>), <b>uterine rupture</b> (no events, one study, 53 women, <a href="./references#CD009792-fig-0016" title="">Analysis 3.5</a>), <b>instrumental vaginal delivery</b> (RR 7.26, 95% CI 0.39 to 134.01, one study, 53 women, <a href="./references#CD009792-fig-0017" title="">Analysis 3.6</a>), <b>postpartum haemorrhage</b> (RR 3.11, 95% CI 0.13 to 73.09, one study, 53 women, <a href="./references#CD009792-fig-0018" title="">Analysis 3.7</a>) and <b>chorioamnionitis</b> (not estimable, one study, 53 women, <a href="./references#CD009792-fig-0019" title="">Analysis 3.8</a>). However the number of events for each of these outcomes was very low and the study did not include enough women to show differences between the groups. Two women in the oxytocin group had scar dehiscence, while none in the Foley catheter group did. </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, uterine hyperstimulation without FHR changes, epidural analgesia, meconium‐stained liquor, Apgar score less than seven at five minutes, neonatal intensive care unit admission, neonatal encephalopathy, perinatal death, disability in childhood, neonatal infection, neonatal antibiotics, maternal side‐effects (all), maternal nausea, maternal vomiting, maternal diarrhoea, other maternal side‐effects, endometritis, maternal antibiotics, serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture), maternal death, woman not satisfied, and caregiver not satisfied. </p> </section> </section> <section id="CD009792-sec-0105"> <h4 class="title">4. Double‐balloon catheter versus vaginal PGE2</h4> <p>One study compared double‐balloon catheter with vaginal PGE2 (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>). Data from the subgroup of women who had had a previous caesarean section were included in this review. See <a href="./full#CD009792-tbl-0004">summary of findings Table 4</a>. </p> <section id="CD009792-sec-0106"> <h5 class="title">Primary outcomes</h5> <p>There was no difference between the groups for <b>caesarean section</b> (RR 0.97, 95% CI 0.41 to 2.32, one study, 16 women, evidence graded very low<i>,</i><a href="./references#CD009792-fig-0020" title="">Analysis 4.1</a>). </p> <p>The study did not report the following primary/GRADE outcomes: <b>vaginal delivery not achieved within 24 hours</b> , <b>uterine hyperstimulation with FHR changes</b> , <b>serious neonatal morbidity or perinatal death</b> , and <b>serious maternal morbidity or death</b>. </p> <p><b>Failed induction</b> was reported (three out of 12 women in the double‐balloon catheter group, and five out of 12 women in the dinoprostone group), however we did not included this outcome in this review as it included women who started labour before induction began and women who had not delivered 48 hours after induction began. </p> </section> <section id="CD009792-sec-0107"> <h5 class="title">Secondary outcomes</h5> <p>No babies in this subgroup of the study were <b>admitted to neonatal unit</b> (not estimable, one study, 20 infants, <a href="./references#CD009792-fig-0021" title="">Analysis 4.2</a>). </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, oxytocin augmentation, uterine hyperstimulation without FHR changes, uterine rupture, epidural analgesia, instrumental vaginal delivery, meconium‐stained liquor, Apgar score less than seven at five minutes, neonatal encephalopathy, perinatal death, disability in childhood, neonatal infection, neonatal antibiotics, maternal side‐effects (all), maternal nausea, maternal vomiting, maternal diarrhoea, other maternal side‐effects, postpartum haemorrhage, chorioamnionitis, endometritis, maternal antibiotics, serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture), maternal death, woman not satisfied, and caregiver not satisfied. </p> </section> </section> <section id="CD009792-sec-0108"> <h4 class="title">5. Oral mifepristone versus Foley catheter</h4> <p>One study compared oral mifepristone versus Foley catheter (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>). No GRADE outcomes were reported. See <a href="./full#CD009792-tbl-0005">summary of findings Table 5</a>. </p> <section id="CD009792-sec-0109"> <h5 class="title">Primary outcomes</h5> <p>The study did not report any of the primary/GRADE outcomes: <b>vaginal delivery not achieved within 24 hours</b> , <b>uterine hyperstimulation with FHR changes</b> , <b>caesarean section</b> , <b>serious neonatal morbidity or perinatal death</b> , and <b>serious maternal morbidity or death</b>. </p> </section> <section id="CD009792-sec-0110"> <h5 class="title">Secondary outcomes</h5> <p>More women who were induced with Foley catheter than mifepristone required further <b>oxytocin augmentation</b> (RR 0.54, 95% CI 0.38 to 0.76, one study, 107 women, <a href="./references#CD009792-fig-0022" title="">Analysis 5.1</a>). The number of women who had a <b>uterine rupture</b> was slightly lower with mifepristone (three out of 57, compared with nine out of 50), however this does not show a clear difference between groups (RR 0.29, 95% CI 0.08 to 1.02, one study, 107 women, <a href="./references#CD009792-fig-0023" title="">Analysis 5.2</a>). </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, uterine hyperstimulation without FHR changes, epidural analgesia, instrumental vaginal delivery, meconium‐stained liquor, Apgar score less than seven at five minutes, neonatal intensive care unit admission, neonatal encephalopathy, perinatal death, disability in childhood, neonatal infection, neonatal antibiotics, maternal side‐effects (all), maternal nausea, maternal vomiting, maternal diarrhoea, other maternal side‐effects, postpartum haemorrhage, chorioamnionitis, endometritis, maternal antibiotics, serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture), maternal death, woman not satisfied, and caregiver not satisfied. </p> </section> </section> <section id="CD009792-sec-0111"> <h4 class="title">6. Vaginal isosorbide mononitrate versus Foley catheter</h4> <p>One study compared vaginal isosorbide mononitrate (IMN) versus Foley catheter (<a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>). See <a href="./full#CD009792-tbl-0006">summary of findings Table 6</a>. </p> <section id="CD009792-sec-0112"> <h5 class="title">Primary outcomes</h5> <p>More women who were induced using IMN rather than Foley catheter had <b>not achieved a vaginal delivery within 24 hours</b> (RR 2.62, 95% CI 1.32 to 5.21, one study, 80 women, evidence graded low<i>,</i><a href="./references#CD009792-fig-0024" title="">Analysis 6.1</a>). There was no difference in the number of women who had a <b>caesarean section</b> (RR 1.00, 95% CI 0.39 to 2.59, one study, 80 women, evidence graded very low<i>,</i><a href="./references#CD009792-fig-0025" title="">Analysis 6.2</a>). </p> <p>The study did not report the following primary/GRADE outcomes: <b>uterine hyperstimulation with FHR changes</b> , <b>serious neonatal morbidity or perinatal death</b> , and <b>serious maternal morbidity or death.</b> </p> </section> <section id="CD009792-sec-0113"> <h5 class="title">Secondary outcomes</h5> <p>More women who in the IMN group compared with the Foley catheter group received <b>oxytocin augmentation</b> (RR 1.65, 95% CI 1.17 to 2.32, one study, 80 women, <a href="./references#CD009792-fig-0026" title="">Analysis 6.3</a>). </p> <p>The number of women may have been too small to show clear differences for some outcomes: slightly more infants in the IMN group had an <b>Apgar score less than seven at five minutes</b> (IMN: 20 out of 40, Foley catheter: 12 out of 40; RR 1.67, 95% CI 0.95 to 2.93, <a href="./references#CD009792-fig-0031" title="">Analysis 6.8</a>); slightly more women experience <b>puerperal pyrexia</b> with Foley catheter (IMN: five out of 40, Foley catheter: 12 out of 40; RR 0.42, 95% CI 0.16 to 1.07, <a href="./references#CD009792-fig-0034" title="">Analysis 6.11</a>); and slightly more women experienced <b>headaches</b> with IMN (IMN: 10 out of 40, Foley catheter: three out of 40; RR 3.33, 95% CI 0.99 to 11.22, <a href="./references#CD009792-fig-0036" title="">Analysis 6.13</a>). </p> <p>In this study of 80 women and infants, there was no clear difference between groups for: <b>uterine rupture</b> (no events, <a href="./references#CD009792-fig-0027" title="">Analysis 6.4</a>); <b>epidural analgesia</b> (RR 1.00, 95% CI 0.39 to 2.59, <a href="./references#CD009792-fig-0028" title="">Analysis 6.5</a>); <b>instrumental vaginal delivery</b> (RR 0.80, 95% CI 0.23 to 2.76, <a href="./references#CD009792-fig-0029" title="">Analysis 6.6</a>); <b>meconium‐stained liquor</b> (RR 2.00, 95% CI 0.19 to 21.18, <a href="./references#CD009792-fig-0030" title="">Analysis 6.7</a>); <b>neonatal intensive care unit admission</b> (RR 2.50, 95% CI 0.51 to 12.14, <a href="./references#CD009792-fig-0032" title="">Analysis 6.9</a>); <b>maternal nausea and vomiting</b> (RR 3.00, 95% CI 0.33 to 27.63, <a href="./references#CD009792-fig-0033" title="">Analysis 6.10</a>); <b>palpitation</b> (RR 2.50, 95% CI 0.51 to 12.14, <a href="./references#CD009792-fig-0035" title="">Analysis 6.12</a>); <b>postpartum haemorrhage</b> (RR 2.00, 95% CI 0.90 to 4.43, <a href="./references#CD009792-fig-0037" title="">Analysis 6.14</a>); and <b>woman not satisfied</b> (RR 1.75, 95% CI 0.56 to 5.51, <a href="./references#CD009792-fig-0038" title="">Analysis 6.15</a>). </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, uterine hyperstimulation without FHR changes, neonatal encephalopathy, perinatal death, disability in childhood, neonatal infection, neonatal antibiotics, maternal side‐effects (all), maternal diarrhoea, chorioamnionitis, endometritis, maternal antibiotics, serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture), maternal death, and caregiver not satisfied. </p> </section> </section> <section id="CD009792-sec-0114"> <h4 class="title">7. Foley catheter (80 mL) versus Foley catheter (30 mL)</h4> <p>One study compared 80 mL Foley catheter versus 30 mL Foley catheter (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>). See <a href="./full#CD009792-tbl-0007">summary of findings Table 7</a>. </p> <section id="CD009792-sec-0115"> <h5 class="title">Primary outcomes</h5> <p>There was no clear difference between groups for <b>vaginal delivery not achieved within 24 hours</b> (RR 1.05, 95% CI 0.91 to 1.20, one study, 154 women, evidence graded moderate<i>,</i><a href="./references#CD009792-fig-0039" title="">Analysis 7.1</a>) and <b>caesarean section</b> (RR 1.05, 95% CI 0.89 to 1.24, one study, 154 women, evidence graded moderate<i>,</i><a href="./references#CD009792-fig-0040" title="">Analysis 7.2</a>). </p> <p>The study did not report the following primary/GRADE outcomes: <b>uterine hyperstimulation with FHR changes</b> , <b>serious neonatal morbidity or perinatal death</b> , and <b>serious maternal morbidity or death</b>. </p> </section> <section id="CD009792-sec-0116"> <h5 class="title">Secondary outcomes</h5> <p>More women who were induced using a 30 mL Foley catheter required <b>oxytocin augmentation</b> (RR 0.81, 95% CI 0.66 to 0.98, one study, 154 women, <a href="./references#CD009792-fig-0041" title="">Analysis 7.3</a>). </p> <p>In this study of 154 women and infants, there was no clear difference between groups for: <b>uterine rupture</b> (RR 1.00, 95% CI 0.06 to 15.70, <a href="./references#CD009792-fig-0042" title="">Analysis 7.4</a>); <b>epidural analgesia</b> (no events, <a href="./references#CD009792-fig-0043" title="">Analysis 7.5</a>); <b>instrumental vaginal delivery</b> (RR 0.92, 95% CI 0.43 to 1.95, <a href="./references#CD009792-fig-0044" title="">Analysis 7.6</a>); <b>Apgar score less than seven at five minutes</b> (RR 1.00, 95% CI 0.06 to 15.70, <a href="./references#CD009792-fig-0045" title="">Analysis 7.7</a>); <b>neonatal intensive care unit admission</b> (RR 2.00, 95% CI 0.19 to 21.60, <a href="./references#CD009792-fig-0046" title="">Analysis 7.8</a>); <b>neonatal encephalopathy</b> (RR 3.00, 95% CI 0.12 to 72.52, <a href="./references#CD009792-fig-0047" title="">Analysis 7.9</a>); <b>perinatal death</b> (RR 3.00, 95% CI 0.12 to 72.52, <a href="./references#CD009792-fig-0048" title="">Analysis 7.10</a>); <b>neonatal infection</b> (no events, <a href="./references#CD009792-fig-0049" title="">Analysis 7.11</a>); <b>cord prolapse (other maternal side‐effects)</b> (no events, <a href="./references#CD009792-fig-0050" title="">Analysis 7.12</a>); <b>postpartum haemorrhage</b> (RR 0.33, 95% CI 0.01 to 8.06, <a href="./references#CD009792-fig-0051" title="">Analysis 7.13</a>); and <b>chorioamnionitis</b> (RR 0.33, 95% CI 0.04 to 3.13, <a href="./references#CD009792-fig-0052" title="">Analysis 7.14</a>). </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, uterine hyperstimulation without FHR changes, meconium‐stained liquor, disability in childhood, neonatal antibiotics, maternal side‐effects (all), maternal nausea, maternal vomiting, maternal diarrhoea, endometritis, maternal antibiotics, serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture), maternal death, woman not satisfied, and caregiver not satisfied. </p> </section> </section> <section id="CD009792-sec-0117"> <h4 class="title">8. Vaginal PGE2 tablet versus vaginal PGE2 pessary</h4> <p>One study compared PGE2 (dinoprostone) vaginal tablet versus vaginal pessary (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>). See <a href="./full#CD009792-tbl-0008">summary of findings Table 8</a>. </p> <section id="CD009792-sec-0118"> <h5 class="title">Primary outcomes</h5> <p>There was no clear difference between groups in the number of women requiring a <b>caesarean section</b> (RR 1.09, 95% CI 0.74 to 1.60, one study, 200 women, evidence graded very low, <a href="./references#CD009792-fig-0053" title="">Analysis 8.1</a>)<i>.</i> </p> <p>The study did not report the following primary/GRADE outcomes: <b>vaginal delivery not achieved within 24 hours</b> , <b>uterine hyperstimulation with FHR changes</b> , <b>serious neonatal morbidity or perinatal death</b> , and <b>serious maternal morbidity or death</b>. </p> </section> <section id="CD009792-sec-0119"> <h5 class="title">Secondary outcomes</h5> <p>In this study of 200 women and infants, there was no clear difference between groups for: <b>oxytocin augmentation</b> (RR 1.50, 95% CI 0.81 to 2.78, <a href="./references#CD009792-fig-0054" title="">Analysis 8.2</a>); <b>uterine hyperstimulation (FHR change not mentioned)</b> (RR 0.50, 95% CI 0.05 to 5.43, <a href="./references#CD009792-fig-0055" title="">Analysis 8.3</a>); <b>uterine rupture</b> (RR 0.33, 95% CI 0.01 to 8.09, <a href="./references#CD009792-fig-0056" title="">Analysis 8.4</a>); <b>Apgar score less than seven at five minutes</b> (RR 0.80, 95% CI 0.22 to 2.89, <a href="./references#CD009792-fig-0057" title="">Analysis 8.5</a>); <b>neonatal intensive care unit admission</b> (RR 0.75, 95% CI 0.17 to 3.27, <a href="./references#CD009792-fig-0058" title="">Analysis 8.6</a>); <b>neonatal infection</b> (RR 1.00, 95% CI 0.06 to 15.77, <a href="./references#CD009792-fig-0059" title="">Analysis 8.7</a>); <b>postpartum haemorrhage</b> (RR 1.00, 95% CI 0.14 to 6.96, <a href="./references#CD009792-fig-0060" title="">Analysis 8.8</a>); <b>chorioamnionitis</b> (RR 1.00, 95% CI 0.06 to 15.77, <a href="./references#CD009792-fig-0061" title="">Analysis 8.9</a>); <b>endometritis</b> (RR 1.50, 95% CI 0.26 to 8.79, <a href="./references#CD009792-fig-0062" title="">Analysis 8.10</a>); and <b>maternal intensive care unit admission</b> (no events, <a href="./references#CD009792-fig-0063" title="">Analysis 8.11</a>). </p> <p>The study did not report the following secondary outcomes: cervix unfavourable/unchanged after 12 to 24 hours, epidural analgesia, instrumental vaginal delivery, meconium‐stained liquor, neonatal encephalopathy, perinatal death, disability in childhood, neonatal antibiotics, maternal side‐effects (all), maternal nausea, maternal vomiting, maternal diarrhoea, other maternal side‐effects, maternal antibiotics, maternal death, woman not satisfied, and caregiver not satisfied. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009792-sec-0120" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009792-sec-0120"></div> <section id="CD009792-sec-0121"> <h3 class="title" id="CD009792-sec-0121">Summary of main results</h3> <p>Eight studies were included in this updated review (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), with a total of 707 women participating in these studies, or the eligible subgroups within them. Three studies compared an intervention with intravenous oxytocin: vaginal PGE2 (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), vaginal misoprostol (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), and Foley catheter (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>). One study compared double‐balloon catheter with vaginal PGE2 (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>), one compared oral mifepristone with Foley catheter (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>), and one trial compared vaginal isosorbide mononitrate (a nitric oxide donor) with Foley catheter (<a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>). One study compared 80 mL Foley catheter with 30 mL Foley catheter (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>), and one study compared vaginal PGE2 pessary with vaginal PGE2 tablet (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>). </p> <p>The available evidence from randomised controlled trials relating to methods of induction of labour for women with a prior caesarean section is inadequate. The available studies are underpowered to detect clinically relevant differences in the primary and secondary outcome measures, and many important outcomes were not reported. As the studies compared different methods of labour induction, no meta‐analysis was possible. </p> <p>No clear differences were found between vaginal PGE2 and intravenous oxytocin for the outcomes reported by <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a> (42 women): caesarean section, serious neonatal morbidity or perinatal death, serious maternal morbidity or death, uterine rupture, epidural analgesia, instrumental vaginal delivery, and Apgar score less than seven at five minutes. </p> <p>One woman who received vaginal misoprostol rather than intravenous oxytocin had a uterine rupture and one had a uterine dehiscence, prompting <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> to prematurely end the trial. Despite this, there was no clear difference between groups, possibly due to the small number of participants. None of our other prespecified primary or secondary outcomes were reported in this study of 38 women. </p> <p>One study comparing Foley catheter with intravenous oxytocin in a study of 53 women (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>) found no difference between groups for all reported primary and secondary outcomes: vaginal delivery within 24 hours, uterine stimulation with fetal heart rate changes, caesarean section, oxytocin augmentation, uterine rupture, instrumental vaginal delivery, postpartum haemorrhage, and chorioamnionitis. </p> <p>There was no clear difference between women who were induced using a double‐balloon catheter versus vaginal PGE2 for caesarean section and admission to the neonatal unit in <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a> (26 women) for the outcomes reported: caesarean section, and admission to neonatal unit. 'Failed induction' was reported, however this combined women who had begun labour between randomisation and induction, as well as women who had not delivered 48 hours after induction, so it was not considered meaningful to include this. No other primary or secondary outcomes were reported. </p> <p>None of the primary outcomes were reported by <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> (107 women). Women induced with oral mifepristone received less oxytocin augmentation than those induced with Foley catheter. There were slightly fewer cases of uterine rupture in the mifepristone group, however this was not a clear difference between groups. </p> <p>One study comparing induction with vaginal isosorbide mononitrate (IMN) versus Foley catheter (80 women, <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>) found that fewer women induced with isosorbide mononitrate achieved a vaginal delivery within 24 hours. More women induced with IMN required oxytocin augmentation. There were no clear differences for the other reported outcomes: caesarean section, uterine rupture, epidural analgesia, instrumental vaginal delivery, meconium‐stained liquor, Apgar score less than seven at five minutes, neonatal intensive care unit admission, maternal nausea and vomiting, puerperal pyrexia, palpitation, headache, postpartum haemorrhage, and woman not satisfied. There were slightly more infants with an Apgar score less than seven at five minutes in the IMN group, slightly more women experienced puerperal pyrexia in the Foley catheter group, and slightly more women experienced headaches with IMN, however the low number of participants meant that these were not clear differences between the groups of women. </p> <p><a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a> compared 80 mL Foley catheter with 30 mL Foley catheter (154 women). There was no clear difference between groups for the primary outcomes: vaginal delivery not achieved within 24 hours and caesarean section. More women who were induced using a 30 mL Foley catheter required oxytocin augmentation. There were no clear differences in the other reported secondary outcomes: uterine rupture, epidural analgesia, instrumental vaginal delivery, Apgar score less than seven at five minutes, neonatal intensive care unit admission, neonatal encephalopathy, perinatal death, neonatal infection, cord prolapse, postpartum haemorrhage, and chorioamnionitis. </p> <p>One study of 200 women (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>) showed no difference between induction with vaginal PGE2 pessary and vaginal PGE2 tablet for any of the reported outcomes: caesarean section, oxytocin augmentation, uterine hyperstimulation (FHR change not mentioned), uterine rupture, Apgar score less than seven at five minutes, neonatal intensive care unit admission, neonatal infection, postpartum haemorrhage, chorioamnionitis, endometritis, and maternal intensive care unit admission. </p> </section> <section id="CD009792-sec-0122"> <h3 class="title" id="CD009792-sec-0122">Overall completeness and applicability of evidence</h3> <p>There is insufficient information available from randomised trials to inform the optimal method of induction of labour in women with a prior caesarean birth. Several of the studies were at high risk of bias, and did not report important outcomes. </p> </section> <section id="CD009792-sec-0123"> <h3 class="title" id="CD009792-sec-0123">Quality of the evidence</h3> <p>All of the trials included in this review had design limitations and some had serious design limitations. It would be difficult to blind women or health professionals to these interventions, and only one study described blinding outcome assessors and the health professionals making clinical decisions (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>). One study had high risk of attrition bias due to excluding a high proportion of women from the analysis (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>). The risk of reporting bias was high in two studies, one that reported few of the prespecified outcomes from two arms of a four‐arm study (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>), and one that reported only uterine rupture and was stopped prematurely due to safety concerns (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>). </p> <p>Several studies reported very few of our prespecified outcomes (<a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), or did not report them in a form that could be included in the review. Infant outcomes were especially scarce, with none of our prespecified infant outcomes reported by <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>, <a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a> and <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>. </p> <p>Studies reported none (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>; <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>), one (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>), two (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>), or three (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>) of our five primary/GRADE outcomes. Caesarean section was reported by six studies (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), vaginal delivery not achieved within 24 hours was reported by three studies (<a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>), uterine hyperstimulation with fetal heart rate changes was reported by one study (<a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>), and the composite outcomes serious neonatal morbidity or perinatal death, and serious maternal morbidity or death were reported by one study (<a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). </p> <p>The GRADE level of evidence for outcomes were: moderate (vaginal delivery not achieved within 24 hours, and caesarean section in <a href="./references#CD009792-bbs2-0003" title="CTRI/2014/02/004412 . Randomised trial comparing intrauterine balloon catheter with 30 ml fluid with intrauterine balloon catheter with 80 ml of fluid to start labor in women with one previous caesarean section. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4199 Date first received: 17 February 2014. ManishP , RathoreS , BenjaminSJ , AbrahamA , JeyaseelanV , MathewsJE . A randomised controlled trial comparing 30 ml and 80 ml in Foley catheter for induction of labour after previous caesarean section. Tropical Doctor2016;46(6):205‐11. ">Manish 2016</a>), low (vaginal delivery not achieved within 24 hours, uterine hyperstimulation with fetal heart rate changes, and caesarean section in <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; vaginal delivery not achieved within 24 hours in <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; caesarean section, serious neonatal morbidity or perinatal death, and serious maternal morbidity or death in <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>), and very low (caesarean section in <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; caesarean section in <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; caesarean section in <a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>). </p> <p>Decisions to downgrade the evidence were based on small sample sizes in every comparison, and high risk of bias in some studies (<a href="./references#CD009792-bbs2-0001" title="HassanMF , El‐TohamyO . Comparative study for success rate of vaginal birth after cesarean section following labor induction by two forms of vaginal dinoprostone: a pilot study. Open Journal of Obstetrics and Gynecology2014;4:33‐41. ">Hassan 2014</a>; <a href="./references#CD009792-bbs2-0002" title="LokkegaardE , LundstromM , KjaerMM , ChristensenIJ , PedersenHB , NyholmH . Prospective multi‐centre randomised trial comparing induction of labour with a double‐balloon catheter versus dinoprostone. Journal of Obstetrics and Gynaecology2015;35(8):797‐802. NCT01255839 . A prospective multi‐centre randomised comparison on induction of labour with double‐balloon installation device versus prostaglandin e2 minprostin. clinicaltrials.gov/ct2/show/NCT01255839 Date first received: 6 December 2010. ">Lokkegaard 2015</a>; <a href="./references#CD009792-bbs2-0004" title="MeeteiLT , SuriV , AggarwalN . Induction of labor in patients with previous cesarean section with unfavorable cervix. JMS ‐ Journal of Medical Society2015;28(1):29‐33. ">Meetei 2015</a>; <a href="./references#CD009792-bbs2-0005" title="RezkM , SanadZ , DawoodR , MasoodA , EmarhM , HalabyAA . Intracervical Foley catheter versus vaginal isosorbid mononitrate for induction of labor in women with previous one cesarean section. Journal of Clinical Gynecology and Obstetrics2014;3(2):55‐61. ">Rezk 2014</a>; <a href="./references#CD009792-bbs2-0007" title="SellersSM , Ah‐MoyeM , MacKenzieIZ . Comparison of vaginal prostaglandin E2 and intravenous oxytocin for induction of labour in women previously delivered by caesarean section. 1st European Congress on Prostaglandins in Reproduction; 1988 July 6‐9; Vienna, Austria. 1988:128. TaylorAVG , SellersS , Ah‐MoyeM , MacKenzieIZ . A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. Journal of Obstetrics and Gynaecology1993;13(5):333‐6. ">Taylor 1993</a>). GRADE could not be assessed for misoprostol versus oxytocin (<a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a>) or mifepristone versus Foley catheter (<a href="./references#CD009792-bbs2-0006" title="CTRI/2012/06/002733 . Induction of labor in women with previous one cesarean section: prospective double blind randomized control trial comparing the effect of mifepristone with sweeping stretching and trans‐cervical Folley’s catheterization. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4745 Date first received: 19 June 2012. SharmaC , SoniA , ThakurS , VermaS . Induction of labor in women with previous cesarean section; mifepristone versus trans‐cervical catheter. A randomized controlled trial. International Journal of Gynecology and Obstetrics2015;131(Suppl 5):E216. SharmaC , SoniA , ThakurS , VermaS . Induction of labour in women with previous one caesarean section; mifepristone versus transcervical Foley's catheter. A randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):303. ">Sharma 2015</a>), because none of the prespecified GRADE outcomes were reported. </p> </section> <section id="CD009792-sec-0124"> <h3 class="title" id="CD009792-sec-0124">Potential biases in the review process</h3> <p>The assessment of risk of bias involves subjective judgements. This potential limitation is minimised by following the procedures in the <i>Cochrane Handbook for Systematic Reviews of Interventions (</i><a href="./references#CD009792-bbs2-0034" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>) with review authors independently assessing studies and resolving any disagreement through discussion, and if required involving a third assessor in the decision. </p> </section> <section id="CD009792-sec-0125"> <h3 class="title" id="CD009792-sec-0125">Agreements and disagreements with other studies or reviews</h3> <p>While there is limited information available from randomised trials, lower‐quality evidence is available from observational studies. </p> <p>In a large retrospective population‐based study, <a href="./references#CD009792-bbs2-0043" title="Lydon‐RochelleM , HoltVL , EasterlingTR , MartinDP . Risk of uterine rupture during labor among women with a prior cesarean delivery. New England Journal of Medicine2001;345(1):3‐8. ">Lydon‐Rochelle 2001</a> evaluated the risk of uterine rupture among women with a prior caesarean birth, comparing the risks following the spontaneous onset of labour, as well as following induction of labour (using both prostaglandin and other methods to induce labour). Where labour occurred spontaneously, the risk of uterine rupture was reported to be 5.2 per 1000 women (56 of 10,789 women), increasing to 7.7 per 1000 women (15 of 1960 women) where labour was induced with “non‐prostaglandin” methods, and further increasing to 24.5 per 1000 women (nine of 366 women) where labour was induced with prostaglandin preparations. When expressed as a risk ratio (RR) comparing the chance of uterine rupture among women who had a repeat elective caesarean section, spontaneous labour increased the chance of rupture by three‐fold (RR 3.3, 95% confidence interval (CI) 1.8 to 6.0), induction with non‐prostaglandin methods by almost five‐fold (RR 4.9, 95% CI 2.4 to 9.7), and induction with prostaglandin preparations by over 15.5‐fold (RR 15.6, 95% CI 8.1 to 30.0). Specific information was not presented for different prostaglandin preparations (for example, PGE2, or misoprostol). </p> <p>The US‐based NICHD group conducted a prospective evaluation of women with a prior caesarean birth (<a href="./references#CD009792-bbs2-0039" title="LandonMB , HauthJC , LevenoKJ , SpongCY , LeindeckerS , VarnerMW , et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. New England Journal of Medicine2004;351(25):2581‐9. ">Landon 2004</a>). In this study, induction of labour following the use of prostaglandin medication was associated with a non‐significant increase in risk of uterine rupture when compared with mechanical methods of induction, for example, the Foley catheter (risk of uterine rupture 140 per 10,000 inductions following PGE2 compared with 89 per 10,000 inductions following mechanical dilation of the cervix with a Foley catheter) (<a href="./references#CD009792-bbs2-0039" title="LandonMB , HauthJC , LevenoKJ , SpongCY , LeindeckerS , VarnerMW , et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. New England Journal of Medicine2004;351(25):2581‐9. ">Landon 2004</a>). In contrast, Scottish data from more than 36,000 women with a prior caesarean birth, of whom 4600 women had labour induced with prostaglandins, demonstrated an increased risk of uterine rupture and subsequent perinatal death following prostaglandin induction (risk of uterine rupture 4.5 per 10,000 non‐induced labours versus 11 per 10,000 labours induced with prostaglandins in women with a prior caesarean) (<a href="./references#CD009792-bbs2-0054" title="SmithGC , PellJP , PasupathyD , DobbieR . Factors predisposing to perinatal death related to uterine rupture during attempted vaginal birth after caesarean section: retrospective cohort study. BMJ2004;329(7462):375. ">Smith 2004</a>). Raviasia et al conducted a retrospective cohort study reviewing all births between 1992 and 1998 in a Canadian hospital (<a href="./references#CD009792-bbs2-0051" title="RavasiaDJ , WoodSL , PollardJK . Uterine rupture during induced trial of labor among women with previous cesarean delivery. American Journal of Obstetrics and Gynecology2000;183(5):1176‐9. ">Ravasia 2000</a>). In this series, of the 172 women who underwent induction with prostaglandins, five suffered a uterine rupture (2.9%), compared with one of 129 in women who were induced with a Foley catheter (0.78%), and two of 274 women who did not require cervical ripening (0.73%). In a similar study evaluating mechanical cervical dilation in women with a prior caesarean section, <a href="./references#CD009792-bbs2-0024" title="BujoldE , BlackwellSC , GauthierRJ . Cervical ripening with transcervical Foley catheter and the risk of uterine rupture. Obstetrics &amp; Gynecology2004;103(1):18‐23. ">Bujold 2004</a> demonstrated a similar risk of uterine rupture between Foley catheter induction and spontaneous onset of labour (1.78% versus 1.2%). </p> <p>The risk associated with uterine scar rupture following the use of misoprostol is less well documented. Misoprostol is an oral prostaglandin E1 analogue, licensed for use in the treatment of gastric ulcer disease. There is increasing recognition of its use as a prostaglandin agent to induce labour following oral, vaginal and buccal administration (<a href="./references#CD009792-bbs2-0020" title="AlfirevicZ , WeeksA . Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD001338.pub2] ">Alfirevic 2006</a>; <a href="./references#CD009792-bbs2-0037" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>; <a href="./references#CD009792-bbs2-0045" title="MuzonziniG , HofmeyrGJ . Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD004221.pub2] ">Muzonzini 2004</a>). However, its use to induce labour in women with a previous caesarean has been questioned, with several case reports indicating an increased risk of uterine rupture (<a href="./references#CD009792-bbs2-0022" title="BennettBB . Uterine rupture during induction of labor at term with intravaginal misoprostol. Obstetrics &amp; Gynecology1997;89(5 Pt 2):832‐3. ">Bennett 1997</a>; <a href="./references#CD009792-bbs2-0025" title="Choy‐HeeL , RaynorBD . Misoprostol induction of labor among women with a history of cesarean delivery. American Journal of Obstetrics and Gynecology2001;184(6):1115‐7. ">Choy‐Hee 2001</a>; <a href="./references#CD009792-bbs2-0027" title="CunhaM , BugalhoA , BiqueC , BergstromS . Induction of labor by vaginal misoprostol in patients with previous cesarean delivery. Acta Obstetricia et Gynecologica Scandinavica1999;78(7):653‐4. ">Cunha 1999</a>; <a href="./references#CD009792-bbs2-0049" title="PhillipsK , BerryC , MathersAM . Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin. European Journal of Obstetrics, Gynecology, and Reproductive Biology1996;65(2):175‐6. ">Phillips 1996</a>; <a href="./references#CD009792-bbs2-0050" title="PlautMM , SchwartzML , LubarskySL . Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section. American Journal of Obstetrics and Gynecology1999;180(6 Pt 1):1535‐42. ">Plaut 1999</a>). </p> <p>While there are documented potential risks associated with induction of labour among women with a previous caesarean section, induction of labour is considered by many to be preferable to a repeat elective caesarean section. In an Australian survey of practice relating to care of women with a prior caesarean section in a subsequent birth, two‐thirds of obstetrician respondents indicated that induction of labour was preferable to a repeat elective caesarean (<a href="./references#CD009792-bbs2-0029" title="DoddJ , CrowtherCA . Vaginal birth after caesarean section: a survey of practice in Australia and New Zealand. Australian and New Zealand Journal of Obstetrics and Gynaecology2003;43(3):226‐31. ">Dodd 2003</a>). While manufacturers of both oxytocin and PGE2 specifically list previous caesarean as a contraindication to use in their product information brochures, almost two‐thirds of Australian obstetricians (<a href="./references#CD009792-bbs2-0029" title="DoddJ , CrowtherCA . Vaginal birth after caesarean section: a survey of practice in Australia and New Zealand. Australian and New Zealand Journal of Obstetrics and Gynaecology2003;43(3):226‐31. ">Dodd 2003</a>) and 25% of Canadian obstetricians (<a href="./references#CD009792-bbs2-0023" title="BrillY , KingdomJ , ThomasJ , FraserW , MilneJK , ThomasM , et al. The management of VBAC at term: a survey of Canadian obstetricians. Journal of Obstetrics and Gynaecology Canada: JOGC2003;25(4):300‐10. ">Brill 2003</a>) use vaginal PGE2 in this setting. Additionally, 80% of Australian obstetricians use oxytocin in women with a previous caesarean birth (<a href="./references#CD009792-bbs2-0029" title="DoddJ , CrowtherCA . Vaginal birth after caesarean section: a survey of practice in Australia and New Zealand. Australian and New Zealand Journal of Obstetrics and Gynaecology2003;43(3):226‐31. ">Dodd 2003</a>). These figures are similar to those reported in England, where 76% of obstetricians would consider use of prostaglandin analogues, and 86% of consultants would use oxytocin to induce labour in women with a previous caesarean birth (<a href="./references#CD009792-bbs2-0032" title="GuptaP , ElmardiA , BathulaU , ChandruS , CharlesworthD . Induction of labour in women with one previous caesarean section. Journal of Obstetrics and Gynaecology2011;21(2):131‐3. ">Gupta 2011</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009792-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD009792-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD009792-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009792-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 1 Caesarean section." data-id="CD009792-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 1 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 2 Serious neonatal morbidity or perinatal death." data-id="CD009792-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 2 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 3 Serious maternal morbidity or death." data-id="CD009792-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 3 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 4 Uterine rupture." data-id="CD009792-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 4 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 5 Epidural analgesia." data-id="CD009792-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 5 Epidural analgesia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 6 Instrumental vaginal delivery." data-id="CD009792-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD009792-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vaginal misoprostol versus intravenous oxytocin, Outcome 1 Uterine rupture." data-id="CD009792-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Vaginal misoprostol versus intravenous oxytocin, Outcome 1 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD009792-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD009792-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 3 Caesarean section." data-id="CD009792-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 3 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 4 Oxytocin augmentation." data-id="CD009792-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 4 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 5 Uterine rupture." data-id="CD009792-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 5 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 6 Instrumental vaginal delivery." data-id="CD009792-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 7 Postpartum haemorrhage." data-id="CD009792-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 7 Postpartum haemorrhage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 8 Chorioamnionitis." data-id="CD009792-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 8 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Double‐balloon catheter versus vaginal PGE2, Outcome 1 Caesarean section." data-id="CD009792-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Double‐balloon catheter versus vaginal PGE2, Outcome 1 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Double‐balloon catheter versus vaginal PGE2, Outcome 2 Admission to neonatal unit." data-id="CD009792-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Double‐balloon catheter versus vaginal PGE2, Outcome 2 Admission to neonatal unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral mifepristone versus Foley catheter, Outcome 1 Oxytocin augmentation." data-id="CD009792-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Oral mifepristone versus Foley catheter, Outcome 1 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral mifepristone versus Foley catheter, Outcome 2 Uterine rupture." data-id="CD009792-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Oral mifepristone versus Foley catheter, Outcome 2 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD009792-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 2 Caesarean section." data-id="CD009792-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 3 Oxytocin augmentation." data-id="CD009792-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 3 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 4 Uterine rupture." data-id="CD009792-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 4 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 5 Epidural analgesia." data-id="CD009792-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 5 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 6 Instrumental vaginal delivery." data-id="CD009792-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 7 Meconium‐stained liquor." data-id="CD009792-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 7 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 8 Apgar score &lt; 7 at 5 minutes." data-id="CD009792-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 8 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 9 Neonatal intensive care unit admission." data-id="CD009792-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 9 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 10 Maternal nausea and vomiting." data-id="CD009792-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 10 Maternal nausea and vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 11 Puerperal pyrexia (other maternal side‐effects)." data-id="CD009792-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 11 Puerperal pyrexia (other maternal side‐effects). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 12 Palpitation (other maternal side‐effects)." data-id="CD009792-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 12 Palpitation (other maternal side‐effects). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 13 Headache (other maternal side‐effects)." data-id="CD009792-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 13 Headache (other maternal side‐effects). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 14 Postpartum haemorrhage." data-id="CD009792-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.14</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 14 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-006-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-006-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 15 Woman not satisfied." data-id="CD009792-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.15</div> <div class="figure-caption"> <p>Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 15 Woman not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-006-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD009792-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 2 Caesarean section." data-id="CD009792-fig-0040" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 3 Oxytocin augmentation." data-id="CD009792-fig-0041" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 3 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 4 Uterine rupture." data-id="CD009792-fig-0042" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 4 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 5 Epidural analgesia." data-id="CD009792-fig-0043" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 5 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 6 Instrumental vaginal delivery." data-id="CD009792-fig-0044" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD009792-fig-0045" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 8 Neonatal intensive care unit admission." data-id="CD009792-fig-0046" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 9 Neonatal encephalopathy." data-id="CD009792-fig-0047" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 9 Neonatal encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 10 Perinatal death." data-id="CD009792-fig-0048" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 10 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 11 Neonatal infection." data-id="CD009792-fig-0049" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.11</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 11 Neonatal infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 12 Cord prolapse (other maternal side‐effects)." data-id="CD009792-fig-0050" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.12</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 12 Cord prolapse (other maternal side‐effects). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 13 Postpartum haemorrhage." data-id="CD009792-fig-0051" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.13</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 13 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-007-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-007-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 14 Chorioamnionitis." data-id="CD009792-fig-0052" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.14</div> <div class="figure-caption"> <p>Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 14 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-007-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 1 Caesarean section." data-id="CD009792-fig-0053" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 2 Oxytocin augmentation." data-id="CD009792-fig-0054" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 2 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 3 Uterine hyperstimulation (FHR change not mentioned)." data-id="CD009792-fig-0055" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 3 Uterine hyperstimulation (FHR change not mentioned). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 4 Uterine rupture." data-id="CD009792-fig-0056" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 4 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 5 Apgar score &lt; 7 at 5 minutes." data-id="CD009792-fig-0057" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 5 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 6 Neonatal intensive care unit admission." data-id="CD009792-fig-0058" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 6 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 7 Neonatal infection." data-id="CD009792-fig-0059" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 7 Neonatal infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 8 Postpartum haemorrhage." data-id="CD009792-fig-0060" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 8 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 9 Chorioamnionitis." data-id="CD009792-fig-0061" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 9 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 10 Endometritis." data-id="CD009792-fig-0062" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 10 Endometritis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009792-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/urn:x-wiley:14651858:media:CD009792:CD009792-CMP-008-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_t/tCD009792-CMP-008-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 11 Maternal intensive care unit admission (serious maternal complications)." data-id="CD009792-fig-0063" src="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.11</div> <div class="figure-caption"> <p>Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 11 Maternal intensive care unit admission (serious maternal complications). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/media/CDSR/CD009792/image_n/nCD009792-CMP-008-11.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal PGE2 versus intravenous (IV) oxytocin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal PGE2 compared with IV oxytocin for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with one previous lower segment caesarean section and requiring labour induction due to prolonged pregnancy or pre‐eclampsia, singleton in cephalic presentation, GA ≥ 37 weeks, BS &lt; 9, no cephalopelvic disproportion anticipated<br/> <b>Setting:</b> UK<br/> <b>Intervention:</b> vaginal prostaglandin E2 (2.5 mg pessary)<br/> <b>Comparison:</b> intravenous oxytocin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oxytocin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with prostaglandin E2</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/> (0.22 to 2.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>191 per 1000<br/> (63 to 580) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious neonatal morbidity/perinatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/> (0.13 to 69.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/> (0.13 to 69.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>42<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>GA</b> : gestational age; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Wide CI crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal PGE2 versus intravenous (IV) oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vaginal misoprostol versus intravenous (IV) oxytocin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared with IV oxytocin for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with a previous caesarean section<br/> <b>Setting:</b> USA<br/> <b>Intervention:</b> vaginal misoprostol 25 μg every 6 hours (maximum of 4 doses)<br/> <b>Comparison:</b> intravenous oxytocin "per a standardised infusion protocol" see <a href="./references#CD009792-bbs2-0008" title="WingDA , LovettK , PaulRH . Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstetrics &amp; Gynecology1998;91(5 Pt 2):828‐30. ">Wing 1998</a> (dose/regime not reported) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with misoprostol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oxytocin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vaginal misoprostol versus intravenous (IV) oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Foley catheter versus intravenous (IV) oxytocin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Foley catheter compared with IV oxytocin for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women with a previous low transverse caesarean section, singleton live pregnancy with cephalic presentation, period of gestation &gt; 28 weeks and BS &lt; 5 were included in the study, with unfavourable cervix<br/> <b>Setting:</b> Chandigarh, India. July 2004–November 2005<br/> <b>Intervention:</b> Foley catheter balloon inflated with 30 mL of sterile saline<br/> <b>Comparison:</b> intravenous oxytocin (low dose IV oxytocin, starting at 1 mU/min and increasing if contractions were not frequent after 1 hour) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with oxytocin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Foley catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.47<br/> (0.89 to 2.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>444 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>653 per 1000<br/> (396 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.11<br/> (0.13 to 73.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.45 to 1.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>370 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>344 per 1000<br/> (167 to 711) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Wide confidence interval crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Foley catheter versus intravenous (IV) oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Double‐balloon catheter versus vaginal PGE2</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Double‐balloon catheter compared with vaginal PGE2 for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with a previous caesarean section (subgroup of all women in the study) with intact fetal membranes, cephalic position and unfavourable cervix, with indications for induction of labour<br/> <b>Setting:</b> 7 labour wards in Denmark, December 2002‐September 2005 </p> <p><b>Intervention:</b> double‐balloon catheter inserted through the cervical canal with 80 mL of saline installed stepwise in the uterine balloon and 80 mL saline in the cervicovaginal balloon<br/> <b>Comparison:</b> vaginal prostaglandin E2 (dinoprostone 3 mg vaginal tablet) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with prostaglandin E2</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with double‐balloon catheter</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/> (0.41 to 2.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>571 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>554 per 1000<br/> (234 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One study with design limitations (risk of bias, downgraded 1 level).<br/> <sup>2</sup>Wide confidence interval crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Double‐balloon catheter versus vaginal PGE2</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Oral mifepristone versus Foley catheter</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Oral mifepristone compared with Foley catheter for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section<br/> <b>Setting:</b> India, 2012‐2014<br/> <b>Intervention:</b> oral mifepristone (400 mg) orally at 40 + 5. All women were reassessed 24 hours and 48 hours later. If BS &gt; 6, amniotomy was performed, followed by oxytocin infusion. If after 48 hours, BS was &lt; 6, induction of labour was done with oxytocin infusion<br/> <b>Comparison:</b> Foley catheter with 30 mL normal saline inserted at 40 + 5 </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with mifepristone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Foley catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Oral mifepristone versus Foley catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Vaginal isosorbide mononitrate versus Foley catheter</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal isosorbide mononitrate versus Foley catheter for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women with 1 previous lower segment caesarean section at 37 weeks and beyond, with a BS of ≤ 6, intact membranes, reactive non‐stress test, normal umbilical arterial Doppler indices, absence of labour and willingness of women to participate in the study<br/> <b>Setting:</b> Egypt<br/> <b>Intervention:</b> vaginal isosorbide mononitrate (40 mg) inserted into the posterior fornix of the vagina once<br/> <b>Comparison:</b> Foley catheter No. 14‐16 Fr inserted into the endocervical canal, beyond the internal os and inflated with 50‐60 mL of normal saline </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Foley catheter</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with isosorbide mononitrate</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.63<br/> (1.32 to 5.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>526 per 1000<br/> (264 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.39 to 2.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>80<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>175 per 1000<br/> (68 to 453) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>Fr</b> : French; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> One study with design limitations (risk of bias, downgraded 1 level).<br/> <sup>2</sup> Small sample size (imprecision, downgraded 1 level).<br/> <sup>3</sup> Wide CI crossing the line of no effect, small sample size (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Vaginal isosorbide mononitrate versus Foley catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">80 mL versus 30 mL Foley catheter</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>80 mL Foley catheter versus 30 mL Foley catheter for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> pregnant women who previously had a lower segment CS and now have a singleton cephalic presentation after at least 36 completed weeks, not in labour, with intact membranes and BS of &lt; 6<br/> <b>Setting:</b> a large tertiary centre in South India, which carries out ˜15,000 deliveries every year. October 2011‐December 2013<br/> <b>Intervention:</b> a 16 Fr Foley catheter was introduced into the cervix beyond the internal os and the bulb inflated with 80 mL of sterile water<br/> <b>Comparison:</b> a 16 Fr Foley catheter was introduced into the cervix beyond the internal os and the bulb inflated with 30 mL of sterile water </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with 30 mL Foley catheter</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with 80 mL Foley catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.91 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>818 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>859 per 1000<br/> (745 to 982) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.89 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>766 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>805 per 1000<br/> (682 to 950) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>Fr</b> : French; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Small sample size (imprecision, downgraded 1 level). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">80 mL versus 30 mL Foley catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009792-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Vaginal PGE2 pessary versus vaginal PGE2 tablet</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal PGE2 pessary versus vaginal PGE2 tablet for term labour induction for women with a previous caesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with a previous caesarean section, a live singleton fetus (37‐42 weeks of gestation) in cephalic presentation and a reactive non‐stress test, BS of ≤ 7 before onset of labour, no spontaneous contractions (&lt; 4 contractions within 20 minutes)<br/> <b>Setting:</b> large Governmental hospital, Saudi Arabia. February 2009‐March 2013<br/> <b>Intervention:</b> vaginal PGE2 pessary (10 mg dinoprostone sustained‐release vaginal pessary)<br/> <b>Comparison:</b> vaginal PGE2 tablet (1.5 mg dinoprostone vaginal tablet) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dinoprostone tablet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dinoprostone pessary</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal delivery not achieved within 24 hours</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine hyperstimulation with fetal heart rate changes</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.09<br/> (0.74 to 1.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>200<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1000<br/> (244 to 528) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious neonatal morbidity or perinatal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious maternal morbidity or death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>BS</b> : Bishop score; <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One study with design limitations (risk of bias, downgraded 1 level).<br/> <sup>2</sup>Wide confidence crossing the line of no effect, small sample size (imprecision, downgraded 2 levels). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Vaginal PGE2 pessary versus vaginal PGE2 tablet</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/full#CD009792-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vaginal PGE2 versus intravenous oxytocin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.22, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 69.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 69.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 69.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.93, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.39, 4.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vaginal PGE2 versus intravenous oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vaginal misoprostol versus intravenous oxytocin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.67 [0.16, 84.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vaginal misoprostol versus intravenous oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Foley catheter versus intravenous oxytocin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.89, 2.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.11 [0.13, 73.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.45, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.81, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.26 [0.39, 134.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.11 [0.13, 73.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Foley catheter versus intravenous oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Double‐balloon catheter versus vaginal PGE2</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.41, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Admission to neonatal unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Double‐balloon catheter versus vaginal PGE2</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Oral mifepristone versus Foley catheter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.38, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.08, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Oral mifepristone versus Foley catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Vaginal isosorbide mononitrate versus Foley catheter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.63 [1.32, 5.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.17, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.95, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal nausea and vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.33, 27.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Puerperal pyrexia (other maternal side‐effects) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Palpitation (other maternal side‐effects) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.5 [0.51, 12.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Headache (other maternal side‐effects) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.99, 11.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.90, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Woman not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.56, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Vaginal isosorbide mononitrate versus Foley catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Foley catheter 80 mL versus Foley catheter 30 mL</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.91, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.89, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.66, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.43, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Cord prolapse (other maternal side‐effects) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Foley catheter 80 mL versus Foley catheter 30 mL</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009792-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Vaginal PGE2 pessary versus vaginal PGE2 tablet</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.74, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.81, 2.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Uterine hyperstimulation (FHR change not mentioned) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.22, 2.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.17, 3.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.26, 8.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal intensive care unit admission (serious maternal complications) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Vaginal PGE2 pessary versus vaginal PGE2 tablet</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009792.pub3/references#CD009792-tbl-0016">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009792.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009792-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009792-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009792-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009792-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009792-note-0014">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009792\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009792\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009792\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009792\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009792\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009792.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009792.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009792.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009792.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009792.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727959831"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009792.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727959835"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009792.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb8ccabdc937f',t:'MTc0MDcyNzk2MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 